RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | Bronchial Neoplasms |
|
Accession: | DOID:9001241
|
browse the term
|
Definition: | Tumors or cancer of the BRONCHI. |
Synonyms: | exact_synonym: | bronchial neoplasm; bronchial neoplasms; bronchus neoplasm; neoplasm of bronchus |
| primary_id: | MESH:D001984 |
| xref: | EFO:1000849 |
|
|
|
G |
Alx4 |
ALX homeobox 4 |
ameliorates |
ISO |
|
RGD |
PMID:24037716 |
RGD:153344522 |
NCBI chr 3:79,611,682...79,648,260
Ensembl chr 3:79,611,719...79,648,260
|
|
G |
Ccnd1 |
cyclin D1 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:14674039 |
RGD:13434930 |
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
disease_progression |
ISO |
|
RGD |
PMID:19484794 |
RGD:4140940 |
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO IMP |
DNA:snp:cds:p.T790M (human) DNA:mutations:exons: protein:increased expression:tumor (human) |
RGD |
PMID:15737014 PMID:26059825 PMID:21419590 |
RGD:5131465, RGD:11075076, RGD:5131630 |
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egr1 |
early growth response 1 |
|
ISO |
mRNA:decreased expression:tumor (human) |
RGD |
PMID:11948124 |
RGD:5131942 |
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
ISO |
DNA:hypermethylation:promoter (human) |
RGD |
PMID:19484794 |
RGD:4140940 |
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
|
IMP |
DNA:mutations:cds: |
RGD |
PMID:26059825 |
RGD:11075076 |
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Mir130a |
microRNA 130a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25926378 |
|
NCBI chr 3:69,822,542...69,822,629
Ensembl chr 3:69,822,542...69,822,629
|
|
G |
Mir144 |
microRNA 144 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25926378 |
|
NCBI chr10:62,961,348...62,961,430
Ensembl chr10:62,961,348...62,961,430
|
|
G |
Mir19a |
microRNA 19a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25926378 |
|
NCBI chr15:92,180,912...92,180,993
Ensembl chr15:92,180,912...92,180,993
|
|
G |
Mir345 |
microRNA 345 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25926378 |
|
NCBI chr 6:127,754,027...127,754,122
Ensembl chr 6:127,754,027...127,754,122
|
|
G |
Mir497 |
microRNA 497 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25926378 |
|
NCBI chr10:54,951,514...54,951,582
Ensembl chr10:54,951,505...54,951,584
|
|
G |
Tp53 |
tumor protein p53 |
|
IMP |
DNA:mutations:exons: |
RGD |
PMID:26059825 |
RGD:11075076 |
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
ISO |
mRNA:decreased expression:bronchus, epithelial cell |
RGD |
PMID:10749130 |
RGD:4142527 |
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
protein:increased secretion:lung (human) |
RGD |
PMID:18764914 |
RGD:4145523 |
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:8030748 |
RGD:4143231 |
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
protein:increased expression, alternative forms:lung |
RGD |
PMID:8030748 |
RGD:4143231 |
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
disease_progression |
ISO |
|
RGD |
PMID:18440724 |
RGD:151361285 |
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
|
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Abce1 |
ATP binding cassette subfamily E member 1 |
severity |
ISO |
mRNA, protein:increased expression:lung (human) |
RGD |
PMID:18788636 |
RGD:11046260 |
NCBI chr19:28,205,566...28,230,489
Ensembl chr19:28,205,555...28,230,489
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
|
|
G |
Adam19 |
ADAM metallopeptidase domain 19 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr10:30,491,362...30,583,115
Ensembl chr10:30,491,405...30,583,105
|
|
G |
Adam28 |
ADAM metallopeptidase domain 28 |
exacerbates disease_progression treatment |
ISO |
protein:increased expression:lung |
RGD |
PMID:29882245 PMID:26800504 PMID:30190423 PMID:20112342 |
RGD:153297792, RGD:11531771, RGD:153297795, RGD:153297794 |
NCBI chr15:43,774,463...43,840,726
Ensembl chr15:42,944,467...43,840,672
|
|
G |
Adamtsl3 |
ADAMTS-like 3 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr 1:136,288,793...136,596,986
Ensembl chr 1:136,288,793...136,596,986
|
|
G |
Adgrg6 |
adhesion G protein-coupled receptor G6 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr 1:8,812,889...8,954,239
Ensembl chr 1:8,812,904...8,954,123
|
|
G |
Ahcy |
adenosylhomocysteinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 3:143,569,134...143,584,359
Ensembl chr 3:143,569,094...143,584,393
|
|
G |
Ahr |
aryl hydrocarbon receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12597446 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Akr1a1 |
aldo-keto reductase family 1 member A1 |
disease_progression |
ISO |
|
RGD |
PMID:30727821 |
RGD:27226687 |
NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung |
ClinVar |
PMID:17611497 PMID:18256540 PMID:18392055 PMID:18504432 PMID:18611285 PMID:18954143 PMID:19418217 PMID:19487299 PMID:19853286 PMID:20233444 PMID:20453058 PMID:21464312 PMID:21512767 PMID:21793738 PMID:22538770 PMID:22610119 PMID:22722201 PMID:22722839 PMID:22980975 PMID:23237847 PMID:23348505 PMID:23700467 PMID:23728071 PMID:23934607 PMID:24190505 PMID:24657128 PMID:25157968 PMID:25741868 PMID:26619011 PMID:28492532 More...
|
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alb |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh18a1 |
aldehyde dehydrogenase 18 family, member A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:239,375,657...239,407,956
Ensembl chr 1:239,375,669...239,407,890
|
|
G |
Aldoa |
aldolase, fructose-bisphosphate A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 |
|
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
|
|
G |
Alk |
ALK receptor tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Lung adenocarcinoma |
CTD ClinVar |
PMID:18923525 PMID:20979469 PMID:20979473 PMID:21030459 PMID:21575866 PMID:21791641 PMID:21823889 PMID:21838707 PMID:21948233 PMID:22071784 PMID:22072639 PMID:22135231 PMID:22153831 PMID:22235099 PMID:22277784 PMID:22743652 PMID:22980554 PMID:22999080 PMID:23344087 PMID:24327273 PMID:24670165 PMID:25741868 PMID:26619011 PMID:27993330 More...
|
|
NCBI chr 6:22,879,653...23,599,636
Ensembl chr 6:22,880,625...23,598,034
|
|
G |
Alox12b |
arachidonate 12-lipoxygenase, 12R type |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30258081 |
|
NCBI chr10:53,863,060...53,874,938
Ensembl chr10:53,863,060...53,874,938
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30258081 |
|
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
|
|
G |
Alx1 |
ALX homeobox 1 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr 7:38,157,626...38,177,220
Ensembl chr 7:38,147,117...38,177,220
|
|
G |
Alx4 |
ALX homeobox 4 |
disease_progression |
ISO |
|
RGD |
PMID:18978557 |
RGD:153350135 |
NCBI chr 3:79,611,682...79,648,260
Ensembl chr 3:79,611,719...79,648,260
|
|
G |
Anapc2 |
anaphase promoting complex subunit 2 |
severity |
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:12036940 |
RGD:14696682 |
NCBI chr 3:8,086,434...8,098,182
Ensembl chr 3:8,086,462...8,098,178
|
|
G |
Anp32a |
acidic nuclear phosphoprotein 32 family member A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 8:62,829,099...62,865,443
Ensembl chr 8:62,827,456...62,865,443
|
|
G |
Anxa1 |
annexin A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 |
|
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Anxa5 |
annexin A5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 |
|
NCBI chr 2:119,314,007...119,344,703
Ensembl chr 2:119,314,007...119,353,369
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:1316610 PMID:1338764 PMID:2281069 PMID:8187091 PMID:8381579 PMID:9824584 PMID:10646887 PMID:15311282 PMID:16134147 PMID:17293347 PMID:18433509 PMID:18948947 PMID:20223039 PMID:20685668 PMID:20924072 PMID:21901162 PMID:22135120 PMID:22987206 PMID:23700467 PMID:25157968 PMID:25741868 PMID:27081525 PMID:27993330 PMID:28492532 More...
|
|
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 |
|
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
Apoc3 |
apolipoprotein C3 |
|
ISO |
protein:altered glycosylation:: |
RGD |
PMID:19322776 |
RGD:153344619 |
NCBI chr 8:46,531,478...46,533,658
Ensembl chr 8:46,531,478...46,533,583
|
|
G |
Aqp4 |
aquaporin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
|
|
G |
Araf |
A-Raf proto-oncogene, serine/threonine kinase |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:24569458 PMID:26619011 |
|
NCBI chr X:1,227,392...1,292,356
Ensembl chr X:1,227,392...1,239,073
|
|
G |
Arg1 |
arginase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Arhgap35 |
Rho GTPase activating protein 35 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27158780 |
|
NCBI chr 1:77,202,436...77,319,298
Ensembl chr 1:77,202,436...77,319,298
|
|
G |
Arhgap44 |
Rho GTPase activating protein 44 |
|
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:28527113 |
RGD:401901290 |
NCBI chr10:49,655,583...49,822,876
Ensembl chr10:49,655,584...49,824,297
|
|
G |
Atp5pd |
ATP synthase peripheral stalk subunit d |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 |
|
NCBI chr10:100,657,700...100,662,960
Ensembl chr10:100,657,708...100,663,479
|
|
G |
Atrx |
ATRX, chromatin remodeler |
disease_progression |
ISO |
|
RGD |
PMID:31374064 |
RGD:127285382 |
NCBI chr X:70,850,981...70,997,330
Ensembl chr X:70,850,981...70,997,330
|
|
G |
Axin2 |
axin 2 |
susceptibility disease_progression |
ISO |
DNA:SNP:cds:p.P50S(human) DNA:SNPs::1712 +19 G>A,148 C>T(human) |
RGD |
PMID:16820935 PMID:30346805 |
RGD:151356657, RGD:151356655 |
NCBI chr10:93,893,830...93,927,042
Ensembl chr10:93,899,245...93,926,231
|
|
G |
Azgp1 |
alpha-2-glycoprotein 1, zinc-binding |
|
ISO |
mRNA,protein:increased expression:lung |
RGD |
PMID:17724461 |
RGD:153350134 |
NCBI chr12:16,930,990...16,939,333
Ensembl chr12:16,931,024...16,939,091
|
|
G |
B2m |
beta-2 microglobulin |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:26619011 |
|
NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
|
|
G |
Bap1 |
BRCA1 associated deubiquitinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231345 |
|
NCBI chr16:6,446,709...6,455,535
Ensembl chr16:6,446,709...6,455,535
|
|
G |
Bhlhe41 |
basic helix-loop-helix family, member e41 |
|
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:18223678 |
RGD:151665316 |
NCBI chr 4:178,834,264...178,838,618
Ensembl chr 4:178,834,271...178,838,468
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
exacerbates |
ISO |
mRNA:increased expression:B cell (human) |
RGD |
PMID:33098370 |
RGD:153323293 |
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
ameliorates disease_progression |
ISO |
mRNA:increased expression:lung (human) |
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma |
CTD ClinVar |
PMID:12068308 PMID:12198537 PMID:12447372 PMID:12460918 PMID:12460919 PMID:12619120 PMID:12644542 PMID:12670889 PMID:12794760 PMID:12960123 PMID:14513361 PMID:14602780 PMID:14612909 PMID:14679157 PMID:14688025 PMID:15001635 PMID:15035987 PMID:15126572 PMID:15181070 PMID:15342696 PMID:15356022 PMID:15386408 PMID:15687339 PMID:15998781 PMID:16015629 PMID:16174717 PMID:16187918 PMID:16439621 PMID:16474404 PMID:16772349 PMID:16825433 PMID:17096326 PMID:17119447 PMID:17311103 PMID:17374713 PMID:17488796 PMID:17603483 PMID:17785355 PMID:18039235 PMID:18042262 PMID:18186519 PMID:18368129 PMID:18398503 PMID:18413255 PMID:18794803 PMID:19001320 PMID:19010912 PMID:19018267 PMID:19206169 PMID:19238210 PMID:19376813 PMID:19383316 PMID:19404918 PMID:19537845 PMID:19561230 PMID:19571295 PMID:19913317 PMID:20008640 PMID:20350999 PMID:20413299 PMID:20619739 PMID:20630094 PMID:20818844 PMID:20823850 PMID:20857202 PMID:21062266 PMID:21107320 PMID:21107323 PMID:21129611 PMID:21156289 PMID:21163703 PMID:21426297 PMID:21483012 PMID:21502544 PMID:21639808 PMID:21641636 PMID:21683865 PMID:21784453 PMID:21975775 PMID:22038996 PMID:22039425 PMID:22048237 PMID:22113612 PMID:22135231 PMID:22180495 PMID:22281684 PMID:22310681 PMID:22351686 PMID:22356324 PMID:22389471 PMID:22448344 PMID:22495831 PMID:22536370 PMID:22586120 PMID:22608338 PMID:22649091 PMID:22663011 PMID:22735384 PMID:22743296 PMID:22773810 PMID:22798288 PMID:22805292 PMID:22876591 PMID:22972589 PMID:22997239 PMID:23020132 PMID:23031422 PMID:23251002 PMID:23273605 PMID:23302800 PMID:23325582 PMID:23352452 PMID:23470635 PMID:23524406 PMID:23549875 PMID:23614898 PMID:23685455 PMID:23715574 PMID:23812671 PMID:23833300 PMID:23845441 PMID:23918947 PMID:24033266 PMID:24107445 PMID:24112392 PMID:24163374 PMID:24303953 PMID:24388723 PMID:24446311 PMID:24451042 PMID:24508103 PMID:24512911 PMID:24576830 PMID:24583796 PMID:24586605 PMID:24594804 PMID:24670642 PMID:24717435 PMID:24920063 PMID:25024077 PMID:25037139 PMID:25079330 PMID:25157968 PMID:25265492 PMID:25265494 PMID:25370471 PMID:25399551 PMID:25463315 PMID:25741868 PMID:25950823 PMID:25989278 PMID:26463840 PMID:26619011 PMID:26678033 PMID:27236105 PMID:27276561 PMID:27404270 PMID:27480103 PMID:28492532 PMID:28832562 PMID:28854169 PMID:28891408 PMID:29453417 PMID:29595366 PMID:29907801 PMID:29925953 PMID:31277584 PMID:31336229 PMID:31779674 PMID:31891627 PMID:33040082 PMID:34476331 More...
|
|
NCBI chr 4:68,375,484...68,510,652
Ensembl chr 4:68,384,649...68,510,463
|
|
G |
Btk |
Bruton tyrosine kinase |
exacerbates susceptibility |
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:31803536 PMID:32351880 |
RGD:151347849, RGD:151347848 |
NCBI chr X:97,722,796...97,762,315
Ensembl chr X:97,722,802...97,761,853
|
|
G |
Bzw2 |
basic leucine zipper and W2 domains 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 6:52,828,069...52,888,599
Ensembl chr 6:52,827,661...52,888,628
|
|
G |
Cadm1 |
cell adhesion molecule 1 |
|
IEP |
DNA, mRNA:hypermethylation, decreased expression:promoter:liver |
RGD |
PMID:16814249 |
RGD:2289096 |
NCBI chr 8:47,847,836...48,178,703
Ensembl chr 8:47,847,325...48,182,833
|
|
G |
Calr |
calreticulin |
treatment |
ISO |
human cells and recombinant gene in a mouse model |
RGD |
PMID:18245558 |
RGD:150521698 |
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
|
|
G |
Capg |
capping actin protein, gelsolin like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 |
|
NCBI chr 4:104,594,743...104,611,856
Ensembl chr 4:104,594,753...104,611,856
|
|
G |
Cbx5 |
chromobox 5 |
disease_progression |
ISO |
mRNA,protein:increased expression:lung: |
RGD |
PMID:22900142 |
RGD:9586743 |
NCBI chr 7:134,333,165...134,376,102
Ensembl chr 7:134,331,335...134,375,022
|
|
G |
Cbx7 |
chromobox 7 |
|
ISO |
mRNA,DNA:decreased expression, loss of heterozygosity:lung: |
RGD |
PMID:22214847 |
RGD:9587356 |
NCBI chr 7:111,460,656...111,479,231
Ensembl chr 7:111,460,656...111,477,973
|
|
G |
Ccnd1 |
cyclin D1 |
disease_progression treatment |
ISO |
|
RGD |
PMID:26681199 PMID:19355812 |
RGD:11536846, RGD:13434927 |
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd2 |
cyclin D2 |
disease_progression |
ISO |
|
RGD |
PMID:30308939 |
RGD:151665105 |
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
|
|
G |
Cct5 |
chaperonin containing TCP1 subunit 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 2:82,591,750...82,602,903
Ensembl chr 2:82,590,630...82,602,930
|
|
G |
Cd163 |
CD163 molecule |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr 4:157,085,080...157,118,470
Ensembl chr 4:157,085,093...157,117,878
|
|
G |
Cd44 |
CD44 molecule |
disease_progression |
ISO |
mRNA:splice variants:lung mRNA:increased expression:lung (human) |
RGD |
PMID:18091389 PMID:29537891 |
RGD:2289345, RGD:149735539 |
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cdc73 |
cell division cycle 73 |
exacerbates |
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:21692036 |
RGD:150537041 |
NCBI chr13:55,357,226...55,449,690
Ensembl chr13:55,357,226...55,449,656
|
|
G |
Cdh1 |
cadherin 1 |
|
IDA |
DNA:increased methylation |
RGD |
PMID:16329148 |
RGD:1599556 |
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdk12 |
cyclin-dependent kinase 12 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
|
|
NCBI chr10:83,201,177...83,256,906
Ensembl chr10:83,201,211...83,280,888 Ensembl chr10:83,201,211...83,280,888
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
|
ISO |
protein:increased expression:lung ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar RGD |
PMID:5377176 PMID:7652577 PMID:8528263 PMID:8968104 PMID:9228064 PMID:9425228 PMID:11756559 PMID:15880589 PMID:21801156 PMID:22804906 PMID:23384855 PMID:23546221 PMID:24256466 PMID:25157968 PMID:25741868 PMID:26619011 PMID:28492532 PMID:29774366 PMID:9751261 More...
|
RGD:13464277 |
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdk6 |
cyclin-dependent kinase 6 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:10574260 |
RGD:13464325 |
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung |
ClinVar |
PMID:7780957 PMID:8521414 PMID:9324288 PMID:10491434 PMID:16234564 PMID:16896043 PMID:21462282 PMID:25157968 PMID:25741868 PMID:26619011 PMID:28492532 PMID:35001868 More...
|
|
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Chd4 |
chromodomain helicase DNA binding protein 4 |
susceptibility ameliorates |
ISO |
mRNA:increased expression:lung (human) DNA:missense mutation:CDS:p.D140E (rs7479004) (human) human cells in a mouse model |
RGD |
PMID:28486105 PMID:29667179 PMID:32228507 |
RGD:153323299, RGD:151660359, RGD:153323307 |
NCBI chr 4:157,898,503...157,931,632
Ensembl chr 4:157,899,391...157,931,541
|
|
G |
Chrna3 |
cholinergic receptor nicotinic alpha 3 subunit |
susceptibility |
ISO |
mRNA,protein:decreased expression:lung ClinVar Annotator: match by term: Lung adenocarcinoma DNA:SNPs:multiples:multiples (human) protein:increased expression:lung DNA:SNP: :rs8042374(human) associated with smoking; DNA:SNP: :rs1051730(human) |
ClinVar RGD |
PMID:27993330 PMID:19223495 PMID:25233467 PMID:24686516 PMID:24686516 PMID:20554942 More...
|
RGD:150524354, RGD:151347535, RGD:151347530, RGD:151347530, RGD:150527848 |
NCBI chr 8:55,401,668...55,415,165
Ensembl chr 8:55,401,702...55,415,165
|
|
G |
Chrna5 |
cholinergic receptor nicotinic alpha 5 subunit |
susceptibility disease_progression |
ISO |
DNA:SNP:cds: p.D398N (rs1696996)(human) ClinVar Annotator: match by term: Lung adenocarcinoma mRNA:increased expression:lung DNA:SNP: :rs503464(human) associated with smoking; DNA:SNPs: :rs2036527, rs684513, rs667282(human) DNA:SNP:cds: p.D398N(human) |
ClinVar RGD |
PMID:27993330 PMID:19223495 PMID:20124469 PMID:23314339 PMID:20554942 PMID:19577767 PMID:23430818 More...
|
RGD:150524354, RGD:150527851, RGD:150527849, RGD:150527848, RGD:150524359, RGD:150524356 |
NCBI chr 8:55,369,794...55,398,526
Ensembl chr 8:55,369,794...55,398,146
|
|
G |
Chrnb4 |
cholinergic receptor nicotinic beta 4 subunit |
|
ISO |
mRNA:increased expression:lung DNA:hypomethylation:promoter: |
RGD |
PMID:20124469 PMID:22945651 |
RGD:150527851, RGD:151361154 |
NCBI chr 8:55,417,583...55,437,027
Ensembl chr 8:55,418,313...55,437,027
|
|
G |
Clptm1l |
CLPTM1-like |
susceptibility no_association ameliorates |
ISO |
CTD Direct Evidence: marker/mechanism DNA:SNP: :rs401681(human) DNA:SNP::rs77518573(human) DNA:SNP:: rs4975616(human) DNA:SNP::rs401681(human) DNA:SNP:: rs31490(human) mRNA:increased expression:lung |
CTD RGD |
PMID:22675468 PMID:24386361 PMID:31935503 PMID:19955392 PMID:24861918 PMID:23908149 PMID:23738012 PMID:24366883 PMID:24366883 More...
|
RGD:150537098, RGD:150530635, RGD:150530502, RGD:150530499, RGD:150530498, RGD:150530485, RGD:150530483, RGD:150530483 |
NCBI chr 1:29,667,545...29,683,530
Ensembl chr 1:29,667,545...29,683,530
|
|
G |
Cmtr2 |
cap methyltransferase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27158780 |
|
NCBI chr19:38,190,718...38,197,549
Ensembl chr19:38,190,642...38,197,804
|
|
G |
Col10a1 |
collagen type X alpha 1 chain |
disease_progression |
ISO |
mRNA:increased expression:lung |
RGD |
PMID:33324550 PMID:33324550 |
RGD:150429752, RGD:150429752 |
NCBI chr20:38,183,103...38,189,488
Ensembl chr20:38,182,494...38,189,494
|
|
G |
Crebbp |
CREB binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27158780 |
|
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
|
ISO |
protein:increased expression:lung (human) |
RGD |
PMID:23702648 |
RGD:150524280 |
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
|
|
G |
Csrp3 |
cysteine and glycine rich protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:98,528,067...98,546,647
Ensembl chr 1:98,528,068...98,546,653
|
|
G |
Ctnnb1 |
catenin beta 1 |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:9065402 PMID:9065403 PMID:9294210 PMID:9500465 PMID:9927029 PMID:10027390 PMID:10192393 PMID:10391090 PMID:10398436 PMID:10435629 PMID:10655994 PMID:10666372 PMID:11351304 PMID:11930117 PMID:11950921 PMID:12124804 PMID:15133491 PMID:23265383 PMID:24788118 PMID:25157968 PMID:25741868 PMID:26619011 PMID:26822237 More...
|
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
exacerbates |
ISO |
protein:increased expression:lung (human) mRNA:increased expression:lung (human) |
RGD |
PMID:30103827 PMID:19716197 |
RGD:152023735, RGD:152177480 |
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
ISO |
protein:increased expression:lung (human) |
RGD |
PMID:19358281 |
RGD:152177688 |
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
ameliorates |
ISO |
DNA:hypomethylation:promoter (human) mRNA:decreased expression:lung (human) human cell line in a mouse model |
RGD |
PMID:24736069 PMID:25519225 PMID:27793774 |
RGD:151361181, RGD:151665499, RGD:151665173 |
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
|
|
G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18669584 |
|
NCBI chr 1:82,231,611...82,244,887
Ensembl chr 1:82,231,611...82,244,887
|
|
G |
Ddr2 |
discoidin domain receptor tyrosine kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Lung adenocarcinoma |
CTD ClinVar |
PMID:26206333 PMID:27993330 |
|
NCBI chr13:82,193,623...82,318,229
Ensembl chr13:82,195,463...82,317,363
|
|
G |
Dll4 |
delta like canonical Notch ligand 4 |
treatment |
IEP |
|
RGD |
PMID:33628824 |
RGD:155663482 |
NCBI chr 3:106,317,114...106,327,004
Ensembl chr 3:106,316,986...106,326,931
|
|
G |
Dnmt3a |
DNA methyltransferase 3 alpha |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:21067377 PMID:21518476 PMID:22160010 PMID:22722925 PMID:22744846 PMID:22898539 PMID:22898541 PMID:24606448 PMID:24622842 PMID:24656771 PMID:25741868 PMID:26619011 PMID:26822784 PMID:26876596 PMID:27317772 PMID:27991732 PMID:28166811 PMID:28252636 PMID:28432085 PMID:28492532 PMID:28941052 PMID:29900417 PMID:30185810 PMID:30478443 PMID:31582562 PMID:31620784 PMID:31640986 PMID:31961069 PMID:32123902 PMID:32385248 PMID:34788385 More...
|
|
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
|
|
G |
Dnmt3b |
DNA methyltransferase 3 beta |
susceptibility |
ISO |
DNA:SNPs,haplotype:promoter:-283T >C,-579G>T(human) |
RGD |
PMID:15528220 |
RGD:9589086 |
NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124
|
|
G |
Dok1 |
docking protein 1 |
disease_progression |
ISO |
|
RGD |
PMID:20139980 |
RGD:152177521 |
NCBI chr 4:115,537,453...115,540,464
Ensembl chr 4:115,537,462...115,540,465
|
|
G |
Dok2 |
docking protein 2 |
disease_progression exacerbates |
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:20139980 PMID:30475228 PMID:20139980 PMID:24255704 |
RGD:152177521, RGD:152177492, RGD:152177521, RGD:152177493 |
NCBI chr15:45,826,984...45,841,409
Ensembl chr15:45,827,398...45,841,402
|
|
G |
Dok3 |
docking protein 3 |
disease_progression |
ISO |
|
RGD |
PMID:20139980 |
RGD:152177521 |
NCBI chr17:9,109,633...9,115,188
Ensembl chr17:9,109,597...9,115,188
|
|
G |
Dot1l |
DOT1 like histone lysine methyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27158780 |
|
NCBI chr 7:8,918,764...8,959,474
Ensembl chr 7:8,917,786...8,956,475
|
|
G |
E2f1 |
E2F transcription factor 1 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:26695082 |
RGD:13464334 |
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
E2f3 |
E2F transcription factor 3 |
|
ISO |
|
RGD |
PMID:16938365 |
RGD:13464341 |
NCBI chr17:34,601,756...34,679,139
Ensembl chr17:34,601,830...34,676,253
|
|
G |
Eef2 |
eukaryotic translation elongation factor 2 |
exacerbates |
ISO |
protein:increased expression:lung (human) |
RGD |
PMID:21554491 |
RGD:153298904 |
NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
|
|
G |
Eef2k |
eukaryotic elongation factor-2 kinase |
ameliorates |
ISO |
Human cells in mouse model |
RGD |
PMID:30522114 |
RGD:153298964 |
NCBI chr 1:175,393,119...175,456,756
Ensembl chr 1:175,393,154...175,455,164
|
|
G |
Egf |
epidermal growth factor |
|
ISO |
DNA:polymorphism: :p.A61G (human) |
RGD |
PMID:26625757 |
RGD:11538684 |
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egfr |
epidermal growth factor receptor |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Adenocarcinoma of lung, somatic | ClinVar Annotator: match by term: Lung adenocarcinoma |
CTD ClinVar RGD |
PMID:2302402 PMID:11423618 PMID:15118073 PMID:15118125 PMID:15272417 PMID:15329413 PMID:15604253 PMID:15623594 PMID:15625347 PMID:15625379 PMID:15710947 PMID:15728811 PMID:15737014 PMID:15738541 PMID:15741570 PMID:15788655 PMID:15897572 PMID:15901872 PMID:15998907 PMID:16011858 PMID:16105816 PMID:16115929 PMID:16187797 PMID:16199108 PMID:16203769 PMID:16204011 PMID:16204070 PMID:16258541 PMID:16467085 PMID:16533793 PMID:16863509 PMID:16865253 PMID:16912157 PMID:16956694 PMID:17020982 PMID:17047654 PMID:17085664 PMID:17106442 PMID:17177598 PMID:17192902 PMID:17236554 PMID:17285735 PMID:17317677 PMID:17332364 PMID:17387341 PMID:17429313 PMID:17473653 PMID:17473659 PMID:17510392 PMID:17726540 PMID:17904685 PMID:17941001 PMID:18093943 PMID:18176089 PMID:18199554 PMID:18227510 PMID:18261621 PMID:18303429 PMID:18325048 PMID:18334834 PMID:18458038 PMID:18596266 PMID:18948947 PMID:18981003 PMID:18992959 PMID:19096301 PMID:19096302 PMID:19096324 PMID:19147750 PMID:19381876 PMID:19455431 PMID:19536777 PMID:19589612 PMID:19671738 PMID:19692680 PMID:19692684 PMID:19922469 PMID:20022809 PMID:20033049 PMID:20038723 PMID:20068085 PMID:20129249 PMID:20479403 PMID:20559149 PMID:20573926 PMID:20808254 PMID:20942962 PMID:21057810 PMID:21194487 PMID:21233402 PMID:21248300 PMID:21252721 PMID:21317742 PMID:21430269 PMID:21527506 PMID:21531810 PMID:21592614 PMID:21670455 PMID:21783417 PMID:21841502 PMID:21899495 PMID:21900837 PMID:21921847 PMID:22019513 PMID:22071784 PMID:22135231 PMID:22215752 PMID:22285168 PMID:22370314 PMID:22452895 PMID:22452896 PMID:22483783 PMID:22588155 PMID:22622260 PMID:22753918 PMID:22760226 PMID:22809298 PMID:22992668 PMID:23102728 PMID:23242437 PMID:23371856 PMID:23468066 PMID:23540867 PMID:23816960 PMID:23816963 PMID:23945392 PMID:23948351 PMID:24033266 PMID:24039832 PMID:24065731 PMID:24202392 PMID:24212795 PMID:24453288 PMID:24478319 PMID:24623981 PMID:24636847 PMID:24658966 PMID:24729716 PMID:24736066 PMID:24736080 PMID:24893891 PMID:24894453 PMID:25061320 PMID:25157968 PMID:25382819 PMID:25668228 PMID:25741868 PMID:25923549 PMID:25923550 PMID:26066407 PMID:26490356 PMID:26515464 PMID:26619011 PMID:26700910 PMID:26720284 PMID:27294619 PMID:27993330 PMID:28144970 PMID:28492532 PMID:28947568 PMID:29100434 PMID:29228562 PMID:30098700 PMID:30610926 PMID:31396478 PMID:31721094 PMID:32171629 PMID:32978515 PMID:32978518 PMID:33858029 PMID:1111234672 PMID:26824984 More...
|
RGD:126790475 |
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Ehmt2 |
euchromatic histone lysine methyltransferase 2 |
disease_progression |
ISO |
|
RGD |
PMID:20940408 |
RGD:9589170 |
NCBI chr20:3,919,623...3,936,751
Ensembl chr20:3,919,624...3,941,547
|
|
G |
Eif2b1 |
eukaryotic translation initiation factor 2B subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr12:32,025,593...32,033,848
Ensembl chr12:32,025,557...32,046,601
|
|
G |
Eif2b4 |
eukaryotic translation initiation factor 2B subunit delta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24366584 |
|
NCBI chr 6:25,183,177...25,188,832
Ensembl chr 6:25,183,186...25,188,829
|
|
G |
Eif2b5 |
eukaryotic translation initiation factor 2B subunit epsilon |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24366584 |
|
NCBI chr11:80,394,433...80,404,468
Ensembl chr11:80,394,433...80,404,419
|
|
G |
Eif3e |
eukaryotic translation initiation factor 3 subunit E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 7:74,339,848...74,372,483
Ensembl chr 7:74,339,828...74,373,096
|
|
G |
Eml4 |
EMAP like 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22980554 PMID:22999080 |
|
NCBI chr 6:11,219,545...11,334,824
Ensembl chr 6:11,219,566...11,334,879
|
|
G |
Emx2 |
empty spiracles homeobox 2 |
exacerbates |
ISO |
mRNA,protein:decreased expression:lung (human) |
RGD |
PMID:21726823 |
RGD:153323303 |
NCBI chr 1:258,626,584...258,633,594
Ensembl chr 1:258,626,584...258,633,594
|
|
G |
Eno1 |
enolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 PMID:27602772 |
|
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336 Ensembl chr 3:160,719,951...160,731,336
|
|
G |
Ep300 |
E1A binding protein p300 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27158780 |
|
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Epha5 |
EPH receptor A5 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:16140923 |
|
NCBI chr14:23,653,393...24,020,129
Ensembl chr14:23,653,393...24,017,317
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
disease_progression |
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar RGD |
PMID:15457249 PMID:15753357 PMID:16638863 PMID:18334834 PMID:22325357 PMID:22761469 PMID:22908275 PMID:24033266 PMID:26619011 PMID:26824984 More...
|
RGD:126790475 |
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
disease_progression |
ISO |
|
RGD |
PMID:26824984 |
RGD:126790475 |
NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
|
|
G |
Erbb4 |
erb-b2 receptor tyrosine kinase 4 |
disease_progression |
ISO |
|
RGD |
PMID:26824984 |
RGD:126790475 |
NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21327329 |
|
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
|
|
G |
Ercc6 |
ERCC excision repair 6, chromatin remodeling factor |
|
ISO |
mRNA, protein:increased expression:lung (human) |
RGD |
PMID:31615563 |
RGD:155260344 |
NCBI chr16:7,764,983...7,835,587
Ensembl chr16:7,765,013...7,835,587
|
|
G |
Ercc6l |
ERCC excision repair 6 like, spindle assembly checkpoint helicase |
exacerbates |
ISO |
mRNA:increased expression:lung (human) |
RGD |
PMID:35150321 |
RGD:155260359 |
NCBI chr X:67,245,414...67,261,222
Ensembl chr X:67,245,414...67,280,756
|
|
G |
Ergic3 |
ERGIC and golgi 3 |
ameliorates disease_progression |
ISO |
mRNA,protein:increased expression:lung (human) |
RGD |
PMID:27588471 PMID:23374247 |
RGD:153323314, RGD:151708716 |
NCBI chr 3:144,525,059...144,534,813
Ensembl chr 3:144,525,092...144,534,813
|
|
G |
Erp29 |
endoplasmic reticulum protein 29 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 |
|
NCBI chr12:35,089,698...35,095,952
Ensembl chr12:35,089,707...35,096,376
|
|
G |
Esco2 |
establishment of sister chromatid cohesion N-acetyltransferase 2 |
ameliorates |
ISO |
|
RGD |
PMID:33573689 |
RGD:155791670 |
NCBI chr15:40,034,566...40,052,295
Ensembl chr15:40,034,568...40,055,306
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
disease_progression |
ISO |
|
RGD |
PMID:24097870 |
RGD:126781716 |
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
|
|
G |
Fas |
Fas cell surface death receptor |
|
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:29254206 |
RGD:151665107 |
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fasn |
fatty acid synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fbl |
fibrillarin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:83,469,832...83,478,932
Ensembl chr 1:83,469,832...83,478,932
|
|
G |
Fbxw7 |
F-box and WD repeat domain containing 7 |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung |
ClinVar |
PMID:26619011 |
|
NCBI chr 2:170,149,706...170,311,536
Ensembl chr 2:170,149,694...170,309,941
|
|
G |
Fes |
FES proto-oncogene, tyrosine kinase |
treatment |
ISO |
human cells in a mouse model |
RGD |
PMID:31573955 |
RGD:153323295 |
NCBI chr 1:134,337,698...134,346,934
Ensembl chr 1:134,337,698...134,346,934
|
|
G |
Fgf10 |
fibroblast growth factor 10 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr 2:50,801,171...50,878,218
Ensembl chr 2:50,800,992...50,876,866
|
|
G |
Fgf18 |
fibroblast growth factor 18 |
|
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:19296538 |
RGD:150429981 |
NCBI chr10:17,706,011...17,737,702
Ensembl chr10:17,706,174...17,736,818
|
|
G |
Fgf9 |
fibroblast growth factor 9 |
disease_progression |
ISO |
protein:increased expression:lung (human) mRNA:decreased expression:lung (human) |
RGD |
PMID:19296538 PMID:19358281 PMID:20464547 |
RGD:150429981 RGD:152177688, RGD:152975620 |
NCBI chr15:32,208,993...32,254,952
Ensembl chr15:32,210,074...32,253,309
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:17525745 PMID:18552176 PMID:22238366 PMID:23002168 PMID:23908597 PMID:25157968 PMID:26619011 More...
|
|
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
|
|
G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung |
ClinVar |
PMID:1908846 PMID:7773297 PMID:8640234 PMID:8858131 PMID:9438390 PMID:9677066 PMID:10073901 PMID:10471491 PMID:10696568 PMID:11241532 PMID:11529856 PMID:12833394 PMID:15772091 PMID:16841094 PMID:18642369 PMID:20301540 PMID:20420824 PMID:22045636 PMID:25157968 PMID:25606676 PMID:25614871 PMID:25741868 PMID:26619011 PMID:28492532 PMID:29593476 PMID:31299979 PMID:36135330 PMID:36474027 More...
|
|
NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341
|
|
G |
Fgfr4 |
fibroblast growth factor receptor 4 |
disease_progression exacerbates |
ISO |
DNA:SNP:exon 9: p.G288R (human) DNA:SNP:exon 9: p.G388R (rs351855)(human) human cells in mouse model |
RGD |
PMID:16061909 PMID:19296538 PMID:29402970 |
RGD:150429976, RGD:150429981, RGD:150429984 |
NCBI chr17:9,461,541...9,476,268
Ensembl chr17:9,461,547...9,476,242
|
|
G |
Fkbp11 |
FKBP prolyl isomerase 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 7:129,871,870...129,877,760
Ensembl chr 7:129,871,870...129,875,303
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
|
|
G |
Foxa1 |
forkhead box A1 |
|
ISO |
mRNA:increased expression:lung CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:34254728 PMID:12234996 PMID:29072684 |
RGD:151665758, RGD:151665822 |
NCBI chr 6:75,099,907...75,136,534
Ensembl chr 6:75,103,503...75,136,188
|
|
G |
Foxo3 |
forkhead box O3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19380174 |
|
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
|
|
G |
Foxp1 |
forkhead box P1 |
|
IEP |
mRNA:decreased expression:lung (rat) |
RGD |
PMID:16023287 |
RGD:11561933 |
NCBI chr 4:131,559,599...132,155,092
Ensembl chr 4:131,564,756...132,112,258
|
|
G |
Foxp2 |
forkhead box P2 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr 4:43,133,827...43,712,442
Ensembl chr 4:43,133,912...43,711,683
|
|
G |
Foxp4 |
forkhead box P4 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr 9:13,058,506...13,115,406
Ensembl chr 9:13,058,476...13,114,879
|
|
G |
Fpr2 |
formyl peptide receptor 2 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr 1:58,776,592...58,785,227
Ensembl chr 1:58,776,752...58,786,019
|
|
G |
Frzb |
frizzled-related protein |
severity |
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:27623992 |
RGD:32716395 |
NCBI chr 3:65,332,274...65,365,208
Ensembl chr 3:65,332,277...65,365,208
|
|
G |
Fubp1 |
far upstream element binding protein 1 |
|
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:32481602 |
RGD:151361197 |
NCBI chr 2:241,159,481...241,186,591
Ensembl chr 2:241,159,512...241,186,602
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
|
|
G |
Gar1 |
GAR1 ribonucleoprotein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 2:218,375,231...218,382,509
Ensembl chr 2:218,375,353...218,382,524
|
|
G |
Gart |
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr11:30,864,896...30,891,125
Ensembl chr11:30,865,889...30,891,125
|
|
G |
Gjb2 |
gap junction protein, beta 2 |
|
IDA |
DNA, mRNA:hypermethylation, decreased expression:lung |
RGD |
PMID:16637067 |
RGD:11568669 |
NCBI chr15:31,260,390...31,278,222
Ensembl chr15:31,260,357...31,278,177
|
|
G |
Gnas |
GNAS complex locus |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung |
ClinVar |
PMID:1517386 PMID:1594625 PMID:1944469 PMID:2549426 PMID:3720010 PMID:7739708 PMID:8766942 PMID:9626141 PMID:10571700 PMID:11093740 PMID:12727968 PMID:12970318 PMID:15126527 PMID:15952988 PMID:16507630 PMID:16543670 PMID:17873334 PMID:20197676 PMID:21835143 PMID:23403822 PMID:23536913 PMID:23843956 PMID:24855271 PMID:25157968 PMID:25719192 PMID:25741868 PMID:26341786 PMID:26574629 PMID:26619011 PMID:27398169 PMID:27506760 PMID:28492532 PMID:29991465 PMID:30702195 More...
|
|
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
|
|
G |
Gng11 |
G protein subunit gamma 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24366584 |
|
NCBI chr 4:32,023,003...32,028,443
Ensembl chr 4:32,023,003...32,028,442
|
|
G |
Gnpnat1 |
glucosamine-phosphate N-acetyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr15:18,596,180...18,608,854
Ensembl chr15:18,596,442...18,608,739
|
|
G |
Golm1 |
golgi membrane protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr17:4,995,925...5,044,329
Ensembl chr17:4,996,104...5,034,057
|
|
G |
Gpi |
glucose-6-phosphate isomerase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:86,828,211...86,856,077
Ensembl chr 1:86,828,216...86,856,086
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
|
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:23374247 |
RGD:151708716 |
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Grwd1 |
glutamate-rich WD repeat containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:96,301,260...96,306,962
Ensembl chr 1:96,301,261...96,307,201
|
|
G |
H1f10 |
H1.10 linker histone |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 4:120,440,515...120,441,578
Ensembl chr 4:120,440,870...120,441,448
|
|
G |
Hells |
helicase, lymphoid specific |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:236,701,704...236,748,239
Ensembl chr 1:236,701,758...236,746,844
|
|
G |
Hk1 |
hexokinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr20:30,230,488...30,332,099
Ensembl chr20:30,230,486...30,332,131
|
|
G |
Hk2 |
hexokinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530
|
|
G |
Hmgb2 |
high mobility group box 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24366584 PMID:27602772 |
|
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140 Ensembl chr 1:32,710,658...32,713,140
|
|
G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609
|
|
G |
Hoxb7 |
homeo box B7 |
severity |
ISO |
protein:increased expression:lung epithelium (human) |
RGD |
PMID:22911672 |
RGD:10402176 |
NCBI chr10:81,252,616...81,256,034
Ensembl chr10:81,252,553...81,256,034
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma |
CTD ClinVar |
PMID:1904555 PMID:3510078 PMID:11150980 PMID:12835555 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17211612 PMID:17384584 PMID:17412879 PMID:17601930 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19213030 PMID:19255327 PMID:19371735 PMID:19382114 PMID:19669404 PMID:19773371 PMID:20301680 PMID:20660566 PMID:20859122 PMID:20937837 PMID:20979192 PMID:21438134 PMID:21495179 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22256804 PMID:22317973 PMID:22420426 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22726224 PMID:22926243 PMID:23093928 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23751039 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24390138 PMID:24803665 PMID:25157968 PMID:25326635 PMID:25695684 PMID:25741868 PMID:25815234 PMID:25914166 PMID:26467025 PMID:26558449 PMID:26619011 PMID:26778095 PMID:27195699 PMID:27283355 PMID:27444071 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28328122 PMID:28492532 PMID:29493581 PMID:30055033 PMID:30138938 PMID:30191474 PMID:31222966 PMID:31394527 PMID:31560489 PMID:31564432 PMID:31775759 PMID:32165824 PMID:32371413 PMID:32732226 PMID:33027564 PMID:33372952 PMID:34008892 PMID:34958143 PMID:168335863 More...
|
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Hsd17b10 |
hydroxysteroid (17-beta) dehydrogenase 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 |
|
NCBI chr X:21,089,142...21,091,603
Ensembl chr X:21,089,122...21,109,488
|
|
G |
Hsp90b1 |
heat shock protein 90 beta family member 1 |
|
ISO |
mRNA:increased expression:lung (human) |
RGD |
PMID:23374247 |
RGD:151708716 |
NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Htr4 |
5-hydroxytryptamine receptor 4 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr18:55,765,981...55,949,921
Ensembl chr18:55,766,725...55,949,321
|
|
G |
Htra1 |
HtrA serine peptidase 1 |
disease_progression |
ISO |
human cells in mouse model |
RGD |
PMID:24356998 |
RGD:152975621 |
NCBI chr 1:185,497,815...185,547,380
Ensembl chr 1:185,497,735...185,547,379
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
disease_progression |
ISO |
mRNA:increased expression:lung (human) ClinVar Annotator: match by term: Adenocarcinoma of lung protein:increased expression:blood plasma (human) |
ClinVar RGD |
PMID:18772396 PMID:19657110 PMID:19798509 PMID:19818334 PMID:20946881 PMID:21352804 PMID:21446021 PMID:22160010 PMID:22397365 PMID:22417203 PMID:22898539 PMID:23558169 PMID:24606448 PMID:25043048 PMID:25157968 PMID:25741868 PMID:26619011 PMID:27993330 PMID:30231226 PMID:36201590 PMID:29537891 PMID:24046070 More...
|
RGD:149735539, RGD:149735540 |
NCBI chr 9:66,534,146...66,563,703
Ensembl chr 9:66,534,146...66,563,708
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
severity |
ISO |
protein:increased expression:lung (human) protein:increased expression:blood serum (human) |
RGD |
PMID:30128035 PMID:29465809 |
RGD:149735564, RGD:149735567 |
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
|
|
G |
Igf2r |
insulin-like growth factor 2 receptor |
|
IAGP |
mRNA:deletions: :c.3698_4902del, c.3366_4902del, c.3817_4697del (rat) |
RGD |
PMID:12503077 |
RGD:1298968 |
NCBI chr 1:47,979,109...48,067,501
Ensembl chr 1:47,979,109...48,067,501
|
|
G |
Ikzf1 |
IKAROS family zinc finger 1 |
exacerbates ameliorates |
ISO |
protein:increased expression:lung (human) mRNA:increased expression:lung (human) |
RGD |
PMID:33738286 PMID:32787735 |
RGD:151347632, RGD:150540324 |
NCBI chr14:86,255,065...86,340,839
Ensembl chr14:86,255,065...86,342,416
|
|
G |
Il1r2 |
interleukin 1 receptor type 2 |
disease_progression severity |
ISO |
mRNA:altered expression:lung (human) mRNA:increased expression:lung (human) |
RGD |
PMID:31921619 PMID:29942094 |
RGD:152998982, RGD:152998998 |
NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
|
|
G |
Impdh2 |
inosine monophosphate dehydrogenase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 8:109,256,705...109,261,365
Ensembl chr 8:109,256,728...109,261,359
|
|
G |
Ipo4 |
importin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr15:29,117,365...29,127,382
Ensembl chr15:29,117,365...29,127,285
|
|
G |
Ipo5 |
importin 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr15:97,990,755...98,041,074
Ensembl chr15:98,005,299...98,041,126
|
|
G |
Iqsec1 |
IQ motif and Sec7 domain ArfGEF 1 |
disease_progression |
ISO |
|
RGD |
PMID:24902879 |
RGD:153350085 |
NCBI chr 4:123,168,719...123,488,300
Ensembl chr 4:123,168,719...123,488,172
|
|
G |
Irak3 |
interleukin-1 receptor-associated kinase 3 |
|
ISO |
mRNA:increased expression:lung (human) |
RGD |
PMID:21278795 |
RGD:36049796 |
NCBI chr 7:55,653,949...55,714,371
Ensembl chr 7:55,653,962...55,713,121
|
|
G |
Ireb2 |
iron responsive element binding protein 2 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr 8:55,228,080...55,311,613
Ensembl chr 8:55,228,085...55,311,611
|
|
G |
Jak2 |
Janus kinase 2 |
treatment |
ISO |
human cells in mouse model |
RGD |
PMID:27025877 |
RGD:11574134 |
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24366584 |
|
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Kcnj4 |
potassium inwardly-rectifying channel, subfamily J, member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30512237 |
|
NCBI chr 7:111,047,097...111,074,151
Ensembl chr 7:111,047,094...111,074,151
|
|
G |
Klf5 |
KLF transcription factor 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27158780 |
|
NCBI chr15:76,060,320...76,079,445
Ensembl chr15:76,064,258...76,079,445
|
|
G |
Kmt2c |
lysine methyltransferase 2C |
disease_progression onset |
ISO |
|
RGD |
PMID:32867667 PMID:30821106 |
RGD:151356760, RGD:151356761 |
NCBI chr 4:9,620,638...9,834,787
Ensembl chr 4:9,609,627...9,833,539
|
|
G |
Kpna2 |
karyopherin subunit alpha 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr10:91,933,951...91,946,115
Ensembl chr10:91,933,951...91,946,150
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
|
ISO |
DNA:point mutation:CDS:p.G12C (human) ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma CTD Direct Evidence: marker/mechanism |
ClinVar CTD RGD |
PMID:2278970 PMID:3122217 PMID:6320174 PMID:8143615 PMID:8425762 PMID:11745231 PMID:12460918 PMID:15696205 PMID:16051643 PMID:16361624 PMID:16434492 PMID:16618717 PMID:17384584 PMID:17704260 PMID:18316791 PMID:18794081 PMID:19018267 PMID:19075190 PMID:19114683 PMID:19255327 PMID:19679400 PMID:19773371 PMID:19794967 PMID:20921462 PMID:20921465 PMID:21228335 PMID:21975775 PMID:22071784 PMID:22135231 PMID:22282465 PMID:22407852 PMID:22722830 PMID:23014527 PMID:23182985 PMID:23325582 PMID:23406027 PMID:24045185 PMID:25044103 PMID:25157968 PMID:25184679 PMID:25741868 PMID:26242988 PMID:26463840 PMID:26619011 PMID:28492532 PMID:31666701 PMID:35658005 PMID:11745231 More...
|
RGD:1600465 |
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Ldha |
lactate dehydrogenase A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
|
|
G |
Lect2 |
leukocyte cell-derived chemotaxin 2 |
ameliorates |
ISO |
human cells in mouse model |
RGD |
PMID:30453282 |
RGD:153323337 |
NCBI chr17:8,044,759...8,050,983
Ensembl chr17:8,044,759...8,050,983
|
|
G |
Lmna |
lamin A/C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 |
|
NCBI chr 2:173,939,751...173,960,423
Ensembl chr 2:173,939,751...173,960,423
|
|
G |
Lmnb1 |
lamin B1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
|
|
G |
Lrp1b |
LDL receptor related protein 1B |
disease_progression |
ISO |
DNA:mutations:multiple: (human) |
RGD |
PMID:18948947 |
RGD:11064706 |
NCBI chr 3:24,594,302...26,715,037
Ensembl chr 3:24,594,991...26,715,505
|
|
G |
Lrrc56 |
leucine rich repeat containing 56 |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:1904555 PMID:3510078 PMID:11150980 PMID:12835555 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17211612 PMID:17384584 PMID:17412879 PMID:17601930 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19213030 PMID:19255327 PMID:19371735 PMID:19382114 PMID:19669404 PMID:19773371 PMID:20301680 PMID:20660566 PMID:20859122 PMID:20937837 PMID:20979192 PMID:21438134 PMID:21495179 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22256804 PMID:22317973 PMID:22420426 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22726224 PMID:22926243 PMID:23093928 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23751039 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24390138 PMID:24803665 PMID:25157968 PMID:25326635 PMID:25695684 PMID:25741868 PMID:25815234 PMID:25914166 PMID:26467025 PMID:26619011 PMID:26778095 PMID:27195699 PMID:27283355 PMID:27444071 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28328122 PMID:28492532 PMID:29493581 PMID:30055033 PMID:30138938 PMID:30191474 PMID:31222966 PMID:31394527 PMID:31560489 PMID:31564432 PMID:31775759 PMID:32165824 PMID:32371413 PMID:32732226 PMID:33027564 PMID:33372952 PMID:34008892 PMID:34958143 PMID:168335863 More...
|
|
NCBI chr 1:196,299,843...196,315,170
Ensembl chr 1:196,299,846...196,315,172
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma mRNA:increased expression:lung (human) |
CTD ClinVar RGD |
PMID:18632602 PMID:21383288 PMID:22135231 PMID:22197931 PMID:22588879 PMID:23444215 PMID:24448821 PMID:25157968 PMID:25741868 PMID:26619011 PMID:29643386 PMID:29254206 More...
|
RGD:151665107 |
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Map2k4 |
mitogen activated protein kinase kinase 4 |
severity |
ISO |
|
RGD |
PMID:21896780 PMID:12231543 |
RGD:150429783, RGD:150429821 |
NCBI chr10:50,343,227...50,447,956
Ensembl chr10:50,344,915...50,447,993
|
|
G |
Map2k7 |
mitogen activated protein kinase kinase 7 |
exacerbates |
ISO |
human gene in a mouse model |
RGD |
PMID:34236045 |
RGD:155230828 |
NCBI chr12:2,591,312...2,600,534
Ensembl chr12:2,591,219...2,604,222
|
|
G |
Map3k8 |
mitogen-activated protein kinase kinase kinase 8 |
exacerbates |
ISO |
|
RGD |
PMID:23533274 |
RGD:151356978 |
NCBI chr17:53,382,908...53,403,216
Ensembl chr17:53,383,131...53,403,216
|
|
G |
Map4k4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
ameliorates exacerbates |
ISO |
human cell line in a mouse model mRNA, protein:increased expression:lung (human) |
RGD |
PMID:22824148 PMID:28306189 PMID:33510968 |
RGD:151347677, RGD:151347678, RGD:151347681 |
NCBI chr 9:42,200,708...42,326,708
Ensembl chr 9:42,200,278...42,326,698
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
exacerbates |
ISO |
mRNA:increased expression:lung (human) |
RGD |
PMID:31969449 |
RGD:151665505 |
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
severity treatment |
ISO |
mRNA:increased expression:lung (human) human cells in mouse model |
RGD |
PMID:31200834 PMID:31200834 |
RGD:151356911, RGD:151356911 |
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
|
|
G |
Meox1 |
mesenchyme homeobox 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:34837450 |
|
NCBI chr10:86,818,450...86,837,563
Ensembl chr10:86,818,478...86,837,660
|
|
G |
Mier3 |
MIER family member 3 |
ameliorates |
ISO |
|
RGD |
PMID:35117188 |
RGD:407571696 |
NCBI chr 2:43,287,546...43,316,422
Ensembl chr 2:43,287,916...43,316,136
|
|
G |
Mir127 |
microRNA 127 |
treatment |
ISO |
Human cells in mouse model |
RGD |
PMID:27869168 |
RGD:152995353 |
NCBI chr 6:128,546,215...128,546,311
Ensembl chr 6:128,546,215...128,546,311
|
|
G |
Mir154 |
microRNA 154 |
|
ISO |
associated with nicotine dependence; RNA:decreased expression:blood serum (human) |
RGD |
PMID:25386559 |
RGD:152995475 |
NCBI chr 6:128,752,947...128,753,030
Ensembl chr 6:128,752,947...128,753,030
|
|
G |
Mir20a |
microRNA 20a |
|
ISO |
|
RGD |
PMID:26560875 |
RGD:11572141 |
NCBI chr15:92,181,084...92,181,168
Ensembl chr15:92,181,084...92,181,168
|
|
G |
Mir21 |
microRNA 21 |
disease_progression |
ISO |
RNA:increased expression:lung (human) miRNA:increased expression:sputum (human) |
RGD |
PMID:29892003 PMID:27777637 |
RGD:152998892, RGD:152998954 |
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mir31 |
microRNA 31 |
severity disease_progression |
ISO |
RNA:increased expression:lung (human) |
RGD |
PMID:26657862 PMID:29367106 PMID:23946296 PMID:27215092 |
RGD:11343268, RGD:152998945, RGD:152998944, RGD:11250998 |
NCBI chr 5:103,599,038...103,599,143
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
disease_progression |
ISO |
protein:altered expression:lung (human) |
RGD |
PMID:26942465 |
RGD:152999419 |
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mlh1 |
mutL homolog 1 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:15340264 PMID:17510385 PMID:18307539 PMID:19419416 PMID:22136435 PMID:22703879 PMID:24033266 PMID:24728327 PMID:25157968 PMID:25741868 PMID:25823662 PMID:27993330 PMID:28492532 More...
|
|
NCBI chr 8:111,196,468...111,233,721
Ensembl chr 8:111,196,468...111,233,617
|
|
G |
Mre11 |
MRE11 homolog, double strand break repair nuclease |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 8:11,618,876...11,680,451
Ensembl chr 8:11,632,354...11,678,279
|
|
G |
Mrpl12 |
mitochondrial ribosomal protein L12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr10:105,758,410...105,762,913
Ensembl chr10:105,758,410...105,762,913
|
|
G |
Mrps5 |
mitochondrial ribosomal protein S5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 3:114,821,046...114,837,291
Ensembl chr 3:114,821,046...114,837,291
|
|
G |
Ms4a1 |
membrane spanning 4-domains A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22514692 |
|
NCBI chr 1:207,906,370...207,927,028
Ensembl chr 1:207,906,374...207,918,512
|
|
G |
Msh2 |
mutS homolog 2 |
no_association |
ISO |
DNA:polymorphisms:introns:IVS10+12A>G, IVS12-6T>C (human) DNA:polymorphisms:promoter, intron:-118T>C, IVS1+9G>C (human) |
RGD |
PMID:16614121 PMID:16614121 |
RGD:11065547, RGD:11065547 |
NCBI chr 6:6,813,793...6,872,960
Ensembl chr 6:6,813,795...6,872,938
|
|
G |
Msh3 |
mutS homolog 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21327329 |
|
NCBI chr 2:23,444,326...23,585,777
|
|
G |
Msh6 |
mutS homolog 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21327329 |
|
NCBI chr 6:6,562,631...6,579,995
Ensembl chr 6:6,562,632...6,579,956
|
|
G |
Muc1 |
mucin 1, cell surface associated |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:8694545 |
RGD:5131260 |
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
|
|
G |
Muc4 |
mucin 4, cell surface associated |
disease_progression |
ISO |
protein:increased expression:trachea |
RGD |
PMID:17126950 |
RGD:5131208 |
NCBI chr11:68,008,245...68,053,242
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr 1:196,864,336...196,896,475
Ensembl chr 1:196,864,336...196,896,475
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
|
ISO |
human cell line in mouse model CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Lung adenocarcinoma |
CTD ClinVar RGD |
PMID:25157968 PMID:26619011 PMID:26656844 PMID:27602772 PMID:20033209 |
RGD:7207787 |
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
treatment ameliorates |
ISO |
mouse cell line in a mouse model |
RGD |
PMID:32140881 PMID:30712876 |
RGD:150520172, RGD:150540309 |
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
|
|
G |
Naa10 |
N(alpha)-acetyltransferase 10, NatA catalytic subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr X:151,656,056...151,661,304
Ensembl chr X:151,656,056...151,661,252
|
|
G |
Naip6 |
NLR family, apoptosis inhibitory protein 6 |
ameliorates |
ISO |
mRNA:increased expression:lung (human) |
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chr 2:31,507,423...31,559,098
Ensembl chr 2:31,507,424...31,570,542
|
|
G |
Ncapg |
non-SMC condensin I complex, subunit G |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34419073 |
|
NCBI chr14:65,403,930...65,432,902
Ensembl chr14:65,404,163...65,432,902
|
|
G |
Ncl |
nucleolin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 9:86,999,588...87,008,112
Ensembl chr 9:86,998,019...87,008,136
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:26619011 PMID:29018201 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nkx2-1 |
NK2 homeobox 1 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr 6:73,996,601...74,001,483
Ensembl chr 6:73,996,601...73,999,791
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nop56 |
NOP56 ribonucleoprotein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 3:117,476,963...117,481,847
Ensembl chr 3:117,477,053...117,481,841
|
|
G |
Nop58 |
NOP58 ribonucleoprotein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 9:61,120,939...61,144,810
Ensembl chr 9:61,120,929...61,144,810
|
|
G |
Notch1 |
notch receptor 1 |
treatment |
IEP |
|
RGD |
PMID:33628824 |
RGD:155663482 |
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
|
|
G |
Npm1 |
nucleophosmin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr10:17,741,512...17,751,626
Ensembl chr10:17,739,941...17,751,645 Ensembl chr X:17,739,941...17,751,645
|
|
G |
Npm3 |
nucleophosmin/nucleoplasmin, 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:244,595,638...244,597,623
Ensembl chr 1:244,595,644...244,597,591
|
|
G |
Nras |
NRAS proto-oncogene, GTPase |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung |
ClinVar |
PMID:1654209 PMID:2278970 PMID:2674680 PMID:3122217 PMID:6587382 PMID:8120410 PMID:10821536 PMID:12460918 PMID:12727991 PMID:14508525 PMID:15899789 PMID:16273091 PMID:16291983 PMID:16434492 PMID:17699718 PMID:18390968 PMID:18633438 PMID:18668139 PMID:18948947 PMID:19075190 PMID:19657110 PMID:19880792 PMID:19966803 PMID:20130576 PMID:20149136 PMID:20179705 PMID:20406486 PMID:20619739 PMID:20736745 PMID:21107323 PMID:21305640 PMID:21576590 PMID:21729679 PMID:21829508 PMID:22407852 PMID:22499344 PMID:22718121 PMID:22761467 PMID:22773810 PMID:23076151 PMID:23392294 PMID:23400451 PMID:23414587 PMID:23515407 PMID:23538902 PMID:23569304 PMID:23614898 PMID:24006476 PMID:24033266 PMID:24148783 PMID:24370118 PMID:24671188 PMID:25157968 PMID:25348872 PMID:25695684 PMID:25741868 PMID:26619011 PMID:26821351 PMID:27050078 PMID:28492532 PMID:28780248 More...
|
|
NCBI chr 2:190,582,885...190,593,509
Ensembl chr 2:190,582,918...190,591,626
|
|
G |
Nudt21 |
nudix hydrolase 21 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr19:10,974,800...10,993,841
Ensembl chr19:10,974,241...10,991,682
|
|
G |
Nuf2 |
NUF2 component of NDC80 kinetochore complex |
disease_progression |
ISO |
|
RGD |
PMID:32226507 |
RGD:28912743 |
NCBI chr13:81,693,675...81,722,765
Ensembl chr13:81,693,598...81,722,766
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23951099 |
|
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
|
|
G |
Pabpc4 |
poly(A) binding protein, cytoplasmic 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 5:135,563,142...135,578,985
Ensembl chr 5:135,563,562...135,578,979
|
|
G |
Pacrg |
parkin coregulated |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:12719539 |
|
NCBI chr 1:49,882,671...50,305,564
Ensembl chr 1:49,882,630...50,305,430
|
|
G |
Pcbd1 |
pterin-4 alpha-carbinolamine dehydratase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr20:29,037,545...29,044,322
Ensembl chr20:28,953,864...29,044,292 Ensembl chr20:28,953,864...29,044,292
|
|
G |
Pign |
phosphatidylinositol glycan anchor biosynthesis, class N |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr13:21,659,092...21,812,932
Ensembl chr13:21,662,455...21,806,790
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma |
CTD ClinVar |
PMID:15016963 PMID:15254419 PMID:15520168 PMID:15608678 PMID:15647370 PMID:15805248 PMID:15930273 PMID:16906227 PMID:16930767 PMID:17376864 PMID:17673550 PMID:18074223 PMID:18676830 PMID:18725974 PMID:19029981 PMID:19223544 PMID:19366826 PMID:19513541 PMID:19903786 PMID:20453058 PMID:20581867 PMID:20593314 PMID:20619739 PMID:21078999 PMID:21430269 PMID:21558396 PMID:21824802 PMID:22135231 PMID:22162582 PMID:22162589 PMID:22209294 PMID:22271473 PMID:22357840 PMID:22370636 PMID:22658544 PMID:22729222 PMID:22729223 PMID:22729224 PMID:23066039 PMID:23100325 PMID:23246288 PMID:23408298 PMID:23888070 PMID:23946963 PMID:24033266 PMID:24265155 PMID:24497998 PMID:24559322 PMID:24782230 PMID:25157968 PMID:25599672 PMID:25681199 PMID:25741868 PMID:25880439 PMID:25915946 PMID:26266975 PMID:26266985 PMID:26351730 PMID:26619011 PMID:26627007 PMID:26637981 PMID:26822237 PMID:26851524 PMID:27126994 PMID:27626068 PMID:27631024 PMID:28151489 PMID:28425981 PMID:28492532 PMID:28566443 PMID:28941273 PMID:29446767 PMID:29549527 PMID:29661094 PMID:29758562 PMID:29988677 PMID:30063105 PMID:30376034 PMID:30543347 PMID:31536475 PMID:31775759 PMID:32778138 PMID:34008892 PMID:34496175 PMID:34568242 PMID:34606700 PMID:36474027 PMID:37667289 PMID:37712948 More...
|
|
NCBI chr 2:115,175,275...115,249,034
Ensembl chr 2:115,174,984...115,249,032
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
|
ISO |
mRNA:decreased expression:lung |
RGD |
PMID:26695082 |
RGD:13464334 |
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
|
|
G |
Pitx2 |
paired-like homeodomain 2 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr 2:217,717,738...217,737,293
Ensembl chr 2:217,717,693...217,737,293
|
|
G |
Plcg1 |
phospholipase C, gamma 1 |
exacerbates |
ISO |
protein:decreased expression:lung (human) |
RGD |
PMID:33077911 |
RGD:151356960 |
NCBI chr 3:149,385,587...149,416,330
Ensembl chr 3:149,385,587...149,416,330
|
|
G |
Plod2 |
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 |
disease_progression |
ISO |
|
RGD |
PMID:29072684 |
RGD:151665822 |
NCBI chr 8:93,084,548...93,167,255
Ensembl chr 8:93,084,513...93,167,255
|
|
G |
Pold1 |
DNA polymerase delta 1, catalytic subunit |
exacerbates |
ISO |
protein:increased expression:lung (human) |
RGD |
PMID:33442399 |
RGD:153323317 |
NCBI chr 1:95,025,462...95,041,559
Ensembl chr 1:95,025,499...95,036,465
|
|
G |
Polr1d |
RNA polymerase I and III subunit D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr12:7,970,592...8,004,157
Ensembl chr12:7,970,595...8,005,624
|
|
G |
Ppan |
peter pan homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 8:19,423,908...19,427,941
Ensembl chr 8:19,423,961...19,427,938
|
|
G |
Ppp2r1a |
protein phosphatase 2 scaffold subunit A alpha |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung |
ClinVar |
PMID:25741868 PMID:26168268 PMID:26619011 PMID:28492532 PMID:31687265 PMID:33106617 PMID:34930662 More...
|
|
NCBI chr 1:60,540,223...60,559,467
Ensembl chr 1:60,540,194...60,560,129
|
|
G |
Ppp3ca |
protein phosphatase 3 catalytic subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27158780 |
|
NCBI chr 2:225,165,981...225,440,978
Ensembl chr 2:225,165,766...225,438,974
|
|
G |
Pramex1 |
PRAME like, X-linked 1 |
|
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:27241212 |
RGD:11535020 |
NCBI chr X:98,567,994...98,574,654
Ensembl chr X:98,569,415...98,572,096
|
|
G |
Prdm1 |
PR/SET domain 1 |
exacerbates |
ISO |
|
RGD |
PMID:28378641 |
RGD:150530469 |
NCBI chr20:47,959,858...47,981,488
Ensembl chr20:47,959,858...47,981,488
|
|
G |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:12719539 |
|
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
|
|
G |
Psat1 |
phosphoserine aminotransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:213,196,709...213,218,564
Ensembl chr 1:213,196,709...213,218,682
|
|
G |
Ptch1 |
patched 1 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar RGD |
PMID:27993330 PMID:28492532 PMID:33359005 |
RGD:150524339 |
NCBI chr17:1,542,705...1,607,730
Ensembl chr17:1,542,877...1,607,333
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Ptpn11 |
protein tyrosine phosphatase, non-receptor type 11 |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung |
ClinVar |
PMID:26619011 PMID:26822237 |
|
NCBI chr12:35,365,436...35,424,925
Ensembl chr12:35,383,144...35,424,925
|
|
G |
Ptpn13 |
protein tyrosine phosphatase, non-receptor type 13 |
exacerbates susceptibility |
ISO |
mRNA,protein:decreased expression:lung DNA:missense mutations:cds:p.I1522M, p.Y2081D (human) |
RGD |
PMID:22245727 PMID:33536603 PMID:19672627 |
RGD:152176663, RGD:152975626, RGD:152176665 |
NCBI chr14:6,108,202...6,282,619
Ensembl chr14:6,108,211...6,282,563
|
|
G |
Ptprb |
protein tyrosine phosphatase, receptor type, B |
disease_progression |
ISO |
mRNA:altered expression:lung (human) mRNA:decreased expression:lung (human) |
RGD |
PMID:29254206 PMID:7981622 |
RGD:151665107, RGD:151665112 |
NCBI chr 7:51,953,375...52,034,751
Ensembl chr 7:51,930,015...52,034,748
|
|
G |
Ptprj |
protein tyrosine phosphatase, receptor type, J |
susceptibility |
ISO |
DNA:missense mutations:cds:p.R326Q, p.Q276P (human) |
RGD |
PMID:19672627 |
RGD:152176665 |
NCBI chr 3:76,405,917...76,561,842
Ensembl chr 3:76,405,927...76,562,260
|
|
G |
Rac1 |
Rac family small GTPase 1 |
exacerbates ameliorates |
ISO |
mRNA:increased expression:lung (human) |
RGD |
PMID:31779616 PMID:32366477 |
RGD:152998910, RGD:153345550 |
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
|
|
G |
Raf1 |
Raf-1 proto-oncogene, serine/threonine kinase |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:1760348 PMID:8601312 PMID:10064593 PMID:12077328 PMID:17603482 PMID:17603483 PMID:19568997 PMID:19953625 PMID:20052757 PMID:20301557 PMID:21440552 PMID:21784453 PMID:22389993 PMID:23312806 PMID:23321623 PMID:23877478 PMID:24033266 PMID:24775816 PMID:24803665 PMID:25706034 PMID:25741868 PMID:26619011 PMID:26918529 PMID:27631234 PMID:28492532 PMID:28777121 PMID:28973083 PMID:28991257 PMID:29084544 PMID:29493581 PMID:29907801 PMID:30055033 PMID:30105547 PMID:30138938 PMID:30384889 PMID:30417923 PMID:30732632 PMID:31324109 PMID:31395954 PMID:31560489 PMID:32410215 PMID:32506814 PMID:32573669 PMID:32668055 PMID:32981126 PMID:33240318 PMID:33318624 PMID:33673806 PMID:34006472 PMID:34136434 PMID:35050212 More...
|
|
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
|
|
G |
Rangrf |
RAN guanine nucleotide release factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr10:53,677,467...53,678,880
Ensembl chr10:53,677,467...53,678,840
|
|
G |
Rarb |
retinoic acid receptor, beta |
|
ISO |
DNA:hypomethylation:lung |
RGD |
PMID:26695082 |
RGD:13464334 |
NCBI chr15:8,700,533...9,051,288
Ensembl chr15:8,406,492...9,051,288
|
|
G |
Rasa1 |
RAS p21 protein activator 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27158780 |
|
NCBI chr 2:15,857,704...15,940,757
Ensembl chr 2:15,857,980...15,940,854
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rbm10 |
RNA binding motif protein 10 |
|
ISO |
mRNA, protein:decreased expression:lung DNA:missense mutations, protein-truncating variants: :multiple |
RGD |
PMID:29085465 PMID:22980975 PMID:30955253 |
RGD:151356983, RGD:11097386, RGD:151356984 |
NCBI chr X:1,540,399...1,572,571
Ensembl chr X:1,540,398...1,572,575
|
|
G |
Rcl1 |
RNA terminal phosphate cyclase-like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:226,824,561...226,869,046
Ensembl chr 1:226,824,534...226,902,315
|
|
G |
Rfc4 |
replication factor C subunit 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr11:77,749,642...77,764,123
Ensembl chr11:77,749,638...77,764,122
|
|
G |
Rhoa |
ras homolog family member A |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:26619011 |
|
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Rin3 |
Ras and Rab interactor 3 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr 6:121,431,776...121,540,956
Ensembl chr 6:121,431,339...121,540,957
|
|
G |
Rnaseh2a |
ribonuclease H2, subunit A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34254728 |
|
NCBI chr19:23,186,325...23,196,045
Ensembl chr19:23,186,383...23,196,041
|
|
G |
Rnf43 |
ring finger protein 43 |
severity |
ISO |
human cells in a mouse model |
RGD |
PMID:31286874 |
RGD:151361222 |
NCBI chr10:72,461,508...72,537,301
Ensembl chr10:72,464,348...72,536,977
|
|
G |
Ros1 |
ROS proto-oncogene 1 , receptor tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Lung adenocarcinoma |
CTD ClinVar |
PMID:22215748 PMID:23724914 PMID:27993330 |
|
NCBI chr20:31,432,636...31,583,998
Ensembl chr20:31,432,637...31,583,865
|
|
G |
Rpl10a |
ribosomal protein L10A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr20:6,388,800...6,391,358
Ensembl chr20:6,385,823...6,391,357 Ensembl chr 9:6,385,823...6,391,357
|
|
G |
Rpl13a |
ribosomal protein L13A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:95,609,374...95,612,557
Ensembl chr 1:95,609,370...95,620,463
|
|
G |
Rpl27a |
ribosomal protein L27A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:163,539,732...163,542,771
|
|
G |
Rpl36a |
ribosomal protein L36A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr X:97,766,179...97,768,892
Ensembl chr X:97,766,179...97,768,892 Ensembl chr20:97,766,179...97,768,892
|
|
G |
Rpsa |
ribosomal protein SA |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 8:119,851,225...119,855,103
Ensembl chr 8:119,851,225...119,855,247
|
|
G |
Rrm1 |
ribonucleotide reductase catalytic subunit M1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:156,823,960...156,848,262
Ensembl chr 1:156,823,960...156,848,261
|
|
G |
Rrm2 |
ribonucleotide reductase regulatory subunit M2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773
|
|
G |
Rrs1 |
ribosome biogenesis regulator 1 homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 5:9,733,486...9,735,119
Ensembl chr 5:9,733,091...9,735,140
|
|
G |
Runx1 |
RUNX family transcription factor 1 |
|
ISO |
|
RGD |
PMID:28926105 |
RGD:126779571 |
NCBI chr11:31,839,880...32,074,427
Ensembl chr11:31,843,764...32,074,542
|
|
G |
Satb1 |
SATB homeobox 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 9:4,677,817...4,773,061
Ensembl chr 9:4,680,920...4,753,251
|
|
G |
Sdc1 |
syndecan 1 |
|
ISO |
mRNA:increased expression:lung (human) |
RGD |
PMID:23374247 |
RGD:151708716 |
NCBI chr 6:31,562,799...31,585,267
Ensembl chr 6:31,562,739...31,585,264
|
|
G |
Serpina3n |
serpin family A member 3N |
|
ISO |
protein:increased expression:cytoplasm |
RGD |
PMID:8620411 |
RGD:5147446 |
NCBI chr 6:123,323,623...123,331,181
Ensembl chr 6:123,323,629...123,332,433
|
|
G |
Setd2 |
SET domain containing 2, histone lysine methyltransferase |
ameliorates exacerbates severity |
ISO |
human cells and genes in mouse model DNA:mutations:multiple (human) |
RGD |
PMID:33223508 PMID:27687306 PMID:33707235 PMID:28202515 |
RGD:150429633, RGD:150429649, RGD:150429648, RGD:126848875 |
NCBI chr 8:110,511,808...110,597,475
Ensembl chr 8:110,511,772...110,597,489
|
|
G |
Sfn |
stratifin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 |
|
NCBI chr 5:145,826,722...145,827,994
Ensembl chr 5:145,826,201...145,831,314
|
|
G |
Sftpc |
surfactant protein C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25851810 |
|
NCBI chr15:45,596,565...45,599,615
Ensembl chr15:45,596,574...45,610,777
|
|
G |
Sfxn1 |
sideroflexin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr17:10,486,250...10,522,640
Ensembl chr17:10,486,271...10,522,529
|
|
G |
Shmt1 |
serine hydroxymethyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr10:45,468,698...45,490,833
Ensembl chr10:45,468,700...45,497,820
|
|
G |
Slc15a2 |
solute carrier family 15 member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr11:64,014,182...64,043,228
Ensembl chr11:64,014,182...64,043,225
|
|
G |
Slc19a1 |
solute carrier family 19 member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr20:11,584,410...11,602,429
Ensembl chr20:11,584,411...11,601,972
|
|
G |
Slc1a5 |
solute carrier family 1 member 5 |
disease_progression |
ISO |
|
RGD |
PMID:26279756 |
RGD:151361150 |
NCBI chr 1:77,456,849...77,470,952
Ensembl chr 1:77,456,694...77,470,952
|
|
G |
Slc22a18 |
solute carrier family 22, member 18 |
disease_progression |
ISO |
mRNA:increased expression:lung (human) ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar RGD |
PMID:27993330 PMID:32726996 |
RGD:150557423 |
NCBI chr 1:198,670,626...198,694,977
Ensembl chr 1:198,671,731...198,694,975
|
|
G |
Slc3a2 |
solute carrier family 3 member 2 |
disease_progression |
ISO |
|
RGD |
PMID:19171406 |
RGD:151361151 |
NCBI chr 1:205,604,468...205,618,931
Ensembl chr 1:205,604,468...205,618,931
|
|
G |
Slc4a4 |
solute carrier family 4 member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr14:18,841,289...19,293,297
Ensembl chr14:18,845,159...19,272,883
|
|
G |
Slc4a7 |
solute carrier family 4 member 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr15:10,585,307...10,664,780
Ensembl chr15:10,588,979...10,664,781
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
disease_progression |
ISO |
|
RGD |
PMID:26279756 PMID:19171406 |
RGD:151361150, RGD:151361151 |
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
|
|
G |
Smad4 |
SMAD family member 4 |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:6604412 PMID:8898652 PMID:9214508 PMID:9285566 PMID:9582123 PMID:9679244 PMID:9811934 PMID:10479724 PMID:10764709 PMID:10775259 PMID:10797267 PMID:11274206 PMID:11583957 PMID:12116240 PMID:12821112 PMID:14715079 PMID:15014009 PMID:15031030 PMID:15235019 PMID:15799969 PMID:16613914 PMID:17132729 PMID:17873119 PMID:17994767 PMID:18823382 PMID:20101697 PMID:20301642 PMID:22316667 PMID:22331366 PMID:25741868 PMID:26572829 PMID:26619011 PMID:26900293 PMID:27595937 PMID:28492532 PMID:31837202 PMID:32300199 PMID:32573726 PMID:32944796 PMID:33326750 More...
|
|
NCBI chr18:67,243,742...67,274,438
Ensembl chr18:67,243,742...67,274,438
|
|
G |
Smarcc1 |
SWI/SNF related BAF chromatin remodeling complex subunit C1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 8:110,111,097...110,214,734
Ensembl chr 8:110,111,122...110,214,720
|
|
G |
Snord22 |
small nucleolar RNA, C/D box 22 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr11:9,097,799...9,097,923
Ensembl chr11:9,097,799...9,097,923
|
|
G |
Snrpb |
small nuclear ribonucleoprotein polypeptides B and B1 |
severity |
ISO |
mRNA:increased expression:lung (human) |
RGD |
PMID:22876301 |
RGD:10768834 |
NCBI chr 3:117,369,816...117,379,344
Ensembl chr 3:117,370,100...117,379,339
|
|
G |
Snrpe |
small nuclear ribonucleoprotein polypeptide E |
severity |
ISO |
mRNA:increased expression:lung (human) |
RGD |
PMID:22876301 |
RGD:10768834 |
NCBI chr13:45,050,986...45,057,231
Ensembl chr13:45,050,986...45,057,310 Ensembl chr 8:45,050,986...45,057,310
|
|
G |
Snrpg |
small nuclear ribonucleoprotein polypeptide G |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 4:118,812,278...118,819,827
Ensembl chr 4:118,812,252...118,819,826 Ensembl chr X:118,812,252...118,819,826
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sos1 |
SOS Ras/Rac guanine nucleotide exchange factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Lung adenocarcinoma |
CTD ClinVar |
PMID:25741868 PMID:26619011 PMID:27158780 |
|
NCBI chr 6:14,533,870...14,613,348
Ensembl chr 6:14,533,360...14,611,107
|
|
G |
Sox2 |
SRY-box transcription factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25184679 |
|
NCBI chr 2:117,536,929...117,539,340
Ensembl chr 2:117,536,929...117,539,338
|
|
G |
Sox30 |
SRY-box transcription factor 30 |
disease_progression |
ISO |
|
RGD |
PMID:26330328 |
RGD:11535423 |
NCBI chr10:30,417,499...30,446,441
Ensembl chr10:30,418,473...30,446,453
|
|
G |
Sox4 |
SRY-box transcription factor 4 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:29882245 |
RGD:153297792 |
NCBI chr17:35,667,809...35,672,515
Ensembl chr17:35,667,537...35,673,665
|
|
G |
Spop |
speckle type BTB/POZ protein |
ameliorates |
ISO |
human gene and cell line in mouse model mRNA, protein:increased expression:lung (human) |
RGD |
PMID:30607139 PMID:31105033 |
RGD:153298920, RGD:153298927 |
NCBI chr10:80,358,121...80,438,983
Ensembl chr10:80,358,124...80,483,955
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
severity |
ISO |
|
RGD |
PMID:12826049 |
RGD:150521546 |
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
Srm |
spermidine synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 5:159,025,875...159,029,076
Ensembl chr 5:159,025,873...159,029,405
|
|
G |
Srr |
serine racemase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr10:59,769,563...59,786,688
Ensembl chr10:59,769,571...59,787,011
|
|
G |
Srsf1 |
serine and arginine rich splicing factor 1 |
severity |
ISO |
|
RGD |
PMID:23071587 |
RGD:150429662 |
NCBI chr10:72,838,926...72,859,066
Ensembl chr10:72,839,274...72,845,336
|
|
G |
Srsf2 |
serine and arginine rich splicing factor 2 |
severity |
ISO |
|
RGD |
PMID:23071587 |
RGD:150429662 |
NCBI chr10:102,052,158...102,055,365
Ensembl chr10:102,052,314...102,055,338
|
|
G |
Stk11 |
serine/threonine kinase 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Lung adenocarcinoma |
CTD ClinVar |
PMID:10408777 PMID:12865922 PMID:15561763 PMID:15863673 PMID:16287113 PMID:16582077 PMID:17026623 PMID:17676035 PMID:19892943 PMID:20393878 PMID:20435009 PMID:23399955 PMID:23718779 PMID:24793789 PMID:25157968 PMID:25226294 PMID:25741868 PMID:26056085 PMID:26467025 PMID:27081308 PMID:27993330 PMID:28152038 PMID:28492532 PMID:30528796 PMID:31159747 More...
|
|
NCBI chr 7:9,574,553...9,591,315
Ensembl chr 7:9,575,269...9,591,315
|
|
G |
Stk39 |
serine threonine kinase 39 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 3:52,913,583...53,179,060
Ensembl chr 3:52,913,585...53,179,060
|
|
G |
Strbp |
spermatid perinuclear RNA binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 3:21,328,310...21,467,753
Ensembl chr 3:21,337,855...21,414,949
|
|
G |
Suclg2 |
succinate-CoA ligase GDP-forming subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 4:128,067,031...128,337,146
Ensembl chr 4:128,067,033...128,337,170
|
|
G |
Sult1a1 |
sulfotransferase family 1A member 1 |
|
ISO |
DNA:SNP:exon:p.R213H, 638G>A (human) |
RGD |
PMID:14688021 |
RGD:1581441 |
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
|
|
G |
Tert |
telomerase reverse transcriptase |
susceptibility |
ISO |
DNA:SNP: :rs2736098(human) DNA:SNP::rs33963617(human) DNA:SNP:: rs2736100(human) DNA:SNPs:: rs2853669,rs2736108(human) |
RGD |
PMID:23738012 PMID:31935503 PMID:24761905 PMID:19955392 PMID:23908149 |
RGD:150530485, RGD:150530635, RGD:150530628, RGD:150530502, RGD:150530498 |
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
|
|
G |
Tf |
transferrin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 |
|
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
|
|
G |
Timm10 |
translocase of inner mitochondrial membrane 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 3:69,908,397...69,911,943
Ensembl chr 3:69,908,456...69,911,940
|
|
G |
Timm8a1 |
translocase of inner mitochondrial membrane 8A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr X:97,717,932...97,722,170
Ensembl chr X:97,717,920...97,721,960
|
|
G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:23374247 |
RGD:151708716 |
NCBI chr 7:17,520,827...17,571,850
Ensembl chr 7:17,521,919...17,571,839
|
|
G |
Tk1 |
thymidine kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920
|
|
G |
Tlr4 |
toll-like receptor 4 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:27993330 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:24345465 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Tomm40 |
translocase of outer mitochondrial membrane 40 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:79,358,781...79,370,882
Ensembl chr 1:79,358,786...79,370,915
|
|
G |
Top2a |
DNA topoisomerase II alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Adenocarcinoma of lung, somatic | ClinVar Annotator: match by term: Lung adenocarcinoma |
CTD ClinVar |
PMID:124622 PMID:253702 PMID:960674 PMID:1349175 PMID:1565143 PMID:1565144 PMID:1569604 PMID:1591732 PMID:1631137 PMID:1631151 PMID:1644930 PMID:1673792 PMID:1679237 PMID:1683921 PMID:1686725 PMID:1737852 PMID:1915267 PMID:1918170 PMID:1978757 PMID:2046748 PMID:2259385 PMID:2531845 PMID:2554494 PMID:2654466 PMID:3784963 PMID:4122735 PMID:6736287 PMID:7478555 PMID:7565304 PMID:7651740 PMID:7707106 PMID:7718482 PMID:7732013 PMID:7737263 PMID:7750099 PMID:7761089 PMID:7783166 PMID:7791795 PMID:7881428 PMID:7885831 PMID:7887414 PMID:8001119 PMID:8023157 PMID:8062826 PMID:8080050 PMID:8099841 PMID:8118819 PMID:8164043 PMID:8242631 PMID:8276238 PMID:8308926 PMID:8336941 PMID:8344492 PMID:8364550 PMID:8401536 PMID:8402598 PMID:8423216 PMID:8425176 PMID:8464896 PMID:8479749 PMID:8527048 PMID:8550239 PMID:8631304 PMID:8633021 PMID:8649776 PMID:8688334 PMID:8718514 PMID:8816796 PMID:8825920 PMID:8829627 PMID:8843196 PMID:8869100 PMID:9020384 PMID:9049183 PMID:9049184 PMID:9067756 PMID:9096669 PMID:9150393 PMID:9157982 PMID:9218725 PMID:9242456 PMID:9268986 PMID:9290701 PMID:9364015 PMID:9399658 PMID:9399838 PMID:9407971 PMID:9418900 PMID:9546439 PMID:9569050 PMID:9572492 PMID:9598730 PMID:9627118 PMID:9632751 PMID:9635828 PMID:9662334 PMID:9667734 PMID:9704930 PMID:9825943 PMID:9839505 PMID:9979965 PMID:10064694 PMID:10089074 PMID:10229196 PMID:10366100 PMID:10411893 PMID:10432928 PMID:10519380 PMID:10567903 PMID:10589545 PMID:10616528 PMID:10629033 PMID:10713666 PMID:10732753 PMID:10753186 PMID:10761705 PMID:10797439 PMID:10864200 PMID:10871862 PMID:10914716 PMID:10922393 PMID:10949938 PMID:11051239 PMID:11051241 PMID:11139324 PMID:11152481 PMID:11180592 PMID:11313981 PMID:11370630 PMID:11429705 PMID:11479205 PMID:11590071 PMID:11593407 PMID:11668501 PMID:11782540 PMID:11793474 PMID:11867759 PMID:11896595 PMID:11900253 PMID:11920788 PMID:11920959 PMID:12007217 PMID:12034820 PMID:12124823 PMID:12406399 PMID:12506399 PMID:12509279 PMID:12672316 PMID:12700230 PMID:12702523 PMID:12726864 PMID:12782597 PMID:12792784 PMID:12826609 PMID:12885464 PMID:12901974 PMID:12909720 PMID:12917626 PMID:14559903 PMID:14584079 PMID:14673037 PMID:14743206 PMID:15004724 PMID:15017592 PMID:15037740 PMID:15077194 PMID:15138567 PMID:15161705 PMID:15221755 PMID:15381368 PMID:15390294 PMID:15541116 PMID:15580553 PMID:15607980 PMID:15607981 PMID:15611505 PMID:15722483 PMID:15781620 PMID:15825182 PMID:15850016 PMID:15925506 PMID:15951970 PMID:15958617 PMID:15977174 PMID:15982667 PMID:15993273 PMID:16206219 PMID:16209708 PMID:16247456 PMID:16258005 PMID:16288208 PMID:16312222 PMID:16322298 PMID:16337994 PMID:16401470 PMID:16474844 PMID:16489069 PMID:16492679 PMID:16494995 PMID:16508005 PMID:16551709 PMID:16633321 PMID:16682957 PMID:16736287 PMID:16741917 PMID:16778209 PMID:16793544 PMID:16818505 PMID:16827139 PMID:16861262 PMID:17015838 PMID:17170001 PMID:17308077 PMID:17311302 PMID:17390010 PMID:17401428 PMID:17417627 PMID:17427234 PMID:17530187 PMID:17540308 PMID:17541742 PMID:17567834 PMID:17572079 PMID:17606709 PMID:17636407 PMID:17724467 PMID:17875924 PMID:17881637 PMID:17974978 PMID:17999388 PMID:18208484 PMID:18307025 PMID:18453682 PMID:18511570 PMID:18555592 PMID:18628487 PMID:18685109 PMID:18689542 PMID:18818522 PMID:18937320 PMID:18978813 PMID:18989156 PMID:19012332 PMID:19101993 PMID:19147582 PMID:19171880 PMID:19336573 PMID:19367287 PMID:19367569 PMID:19378321 PMID:19405127 PMID:19454241 PMID:19462533 PMID:19468865 PMID:19556618 PMID:19681600 PMID:19834951 PMID:19850740 PMID:19913028 PMID:19930417 PMID:20013323 PMID:20028212 PMID:20113312 PMID:20118236 PMID:20127978 PMID:20128691 PMID:20182602 PMID:20195489 PMID:20234365 PMID:20364130 PMID:20407015 PMID:20505364 PMID:20506564 PMID:20516128 PMID:20522432 PMID:20586629 PMID:20589832 PMID:20593220 PMID:20693561 PMID:20805372 PMID:20878954 PMID:20972454 PMID:21056685 PMID:21059199 PMID:21080251 PMID:21113594 PMID:21115975 PMID:21118481 PMID:21159183 PMID:21187651 PMID:21188122 PMID:21232794 PMID:21305319 PMID:21319261 PMID:21331359 PMID:21343334 PMID:21356188 PMID:21445056 PMID:21483000 PMID:21484931 PMID:21514416 PMID:21519010 PMID:21522129 PMID:21535297 PMID:21552135 PMID:21590121 PMID:21601526 PMID:21626334 PMID:21674059 PMID:21747090 PMID:21760960 PMID:21760996 PMID:21761402 PMID:22006311 PMID:22052707 PMID:22090360 PMID:22109999 PMID:22110706 PMID:22186996 PMID:22198284 PMID:22265402 PMID:22319594 PMID:22427690 PMID:22484423 PMID:22551548 PMID:22553421 PMID:22553460 PMID:22672556 PMID:22710932 PMID:22713868 PMID:22811390 PMID:22822097 PMID:22862161 PMID:22869713 PMID:22887876 PMID:22915647 PMID:22919068 PMID:22923379 PMID:22955915 PMID:22983585 PMID:22999923 PMID:23028800 PMID:23031740 PMID:23124483 PMID:23161690 PMID:23165212 PMID:23172776 PMID:23175693 PMID:23246812 PMID:23255406 PMID:23259501 PMID:23263379 PMID:23264849 PMID:23265383 PMID:23334668 PMID:23340422 PMID:23406775 PMID:23484829 PMID:23538418 PMID:23612969 PMID:23625637 PMID:23630318 PMID:23667202 PMID:23713777 PMID:23792586 PMID:23894400 PMID:23939625 PMID:23950206 PMID:23967324 PMID:24033266 PMID:24038938 PMID:24065105 PMID:24076587 PMID:24122735 PMID:24256616 PMID:24307375 PMID:24381225 PMID:24382691 PMID:24384472 PMID:24487413 PMID:24501221 PMID:24549055 PMID:24573247 PMID:24590827 PMID:24603336 PMID:24641375 PMID:24651012 PMID:24651015 PMID:24677579 PMID:24702488 PMID:24728327 PMID:24744791 PMID:24763289 PMID:24810334 PMID:24835218 PMID:24857548 PMID:24940547 PMID:25119136 PMID:25157968 PMID:25186627 PMID:25256166 PMID:25293557 PMID:25294809 PMID:25339994 PMID:25381062 PMID:25404506 PMID:25428789 PMID:25433984 PMID:25503501 PMID:25504633 PMID:25525159 PMID:25584008 PMID:25584637 PMID:25612911 PMID:25619955 PMID:25634208 PMID:25669829 PMID:25691460 PMID:25741868 PMID:25757876 PMID:25765855 PMID:25787918 PMID:25896519 PMID:25925845 PMID:25927356 PMID:25945745 PMID:25952993 PMID:25961455 PMID:25980754 PMID:26014290 PMID:26022348 PMID:26024390 PMID:26066407 PMID:26205489 PMID:26206333 PMID:26225655 PMID:26230955 PMID:26270727 PMID:26271412 PMID:26332594 PMID:26425688 PMID:26467025 PMID:26497680 PMID:26554828 PMID:26556299 PMID:26580448 PMID:26585234 PMID:26619011 PMID:26628864 PMID:26655088 PMID:26659639 PMID:26681312 PMID:26781615 PMID:26786923 PMID:26787237 PMID:26818906 PMID:26822237 PMID:26845104 PMID:26878390 PMID:26911350 PMID:26976419 PMID:27022024 PMID:27077130 PMID:27179933 PMID:27189670 PMID:27276561 PMID:27276934 PMID:27328919 PMID:27374712 PMID:27463065 PMID:27489289 PMID:27493922 PMID:27501770 PMID:27523101 PMID:27533082 PMID:27557517 PMID:27616075 PMID:27621308 PMID:27622479 PMID:27680515 PMID:27683180 PMID:27714481 PMID:27724982 PMID:27726232 PMID:27813088 PMID:27873457 PMID:27895058 PMID:27911860 PMID:27959731 PMID:27993330 PMID:28135145 PMID:28152038 PMID:28160093 PMID:28166194 PMID:28271309 PMID:28279309 PMID:28356770 PMID:28369373 PMID:28453743 PMID:28472496 PMID:28477316 PMID:28492532 PMID:28573494 PMID:28724667 PMID:28772286 PMID:28776571 PMID:28802053 PMID:28861920 PMID:28873162 PMID:28949402 PMID:28973705 PMID:28975465 PMID:29025599 PMID:29058119 PMID:29070607 PMID:29076966 PMID:29126202 PMID:29300620 PMID:29324801 PMID:29470806 PMID:29478780 PMID:29489754 PMID:29581140 PMID:29666004 PMID:29752822 PMID:29753700 PMID:29875428 PMID:29946497 PMID:29958926 PMID:29979965 PMID:30076369 PMID:30099178 PMID:30107044 PMID:30107858 PMID:30128536 PMID:30216591 PMID:30224644 PMID:30287823 PMID:30299350 PMID:30306255 PMID:30311369 PMID:30318520 PMID:30322717 PMID:30327374 PMID:30352134 PMID:30450585 PMID:30546832 PMID:30583724 PMID:30607672 PMID:30630526 PMID:30675318 PMID:30709381 PMID:30709875 PMID:30720243 PMID:30730202 PMID:30816478 PMID:30840781 PMID:30918304 PMID:31016814 PMID:31050713 PMID:31081129 PMID:31105275 PMID:31119730 PMID:31121848 PMID:31127191 PMID:31168460 PMID:31206626 PMID:31296311 PMID:31300551 PMID:31494577 PMID:31748977 PMID:31775759 PMID:31882575 PMID:32000721 PMID:32019277 PMID:32126783 PMID:32156018 PMID:32164171 PMID:32179180 PMID:32187361 PMID:32295079 PMID:32318955 PMID:32371905 PMID:32401780 PMID:32475984 PMID:32658383 PMID:32817165 PMID:32885271 PMID:32888145 PMID:32906206 PMID:32959997 PMID:32980694 PMID:33087929 PMID:33138793 PMID:33163847 PMID:33208383 PMID:33245408 PMID:33300245 PMID:33332384 PMID:33372952 PMID:33407742 PMID:33471991 PMID:33633026 PMID:33635883 PMID:33674644 PMID:33758026 PMID:33818021 PMID:33840814 PMID:34026625 PMID:34049842 PMID:34240179 PMID:34266904 PMID:34308366 PMID:34529667 PMID:34675114 PMID:34709361 PMID:34793666 PMID:34805717 PMID:34994652 PMID:35033608 PMID:35127508 PMID:35264596 PMID:35820297 PMID:35938033 PMID:35974385 PMID:36219266 PMID:36329109 PMID:36988593 More...
|
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tp63 |
tumor protein p63 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24880342 |
|
NCBI chr11:74,838,858...75,049,764
Ensembl chr11:74,838,859...75,049,398
|
|
G |
Tpi1 |
triosephosphate isomerase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 4:157,615,283...157,618,813
Ensembl chr 4:157,615,386...157,619,541
|
|
G |
Traf4 |
Tnf receptor associated factor 4 |
|
ISO |
mRNA:increased expression:lung (human) |
RGD |
PMID:29254206 |
RGD:151665107 |
NCBI chr10:63,054,169...63,060,284
Ensembl chr10:63,054,181...63,060,284
|
|
G |
Ttf1 |
transcription termination factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25851810 |
|
NCBI chr 3:12,384,626...12,409,257
Ensembl chr 3:12,384,655...12,409,257
|
|
G |
Ttr |
transthyretin |
|
ISO |
mRNA,protein:increased expression:lung (human) |
RGD |
PMID:26943652 |
RGD:151665207 |
NCBI chr18:11,941,791...11,951,008
Ensembl chr18:11,943,789...11,951,008
|
|
G |
Tyms |
thymidylate synthetase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
|
|
G |
U2af1 |
U2 small nuclear RNA auxiliary factor 1 |
|
ISO |
ClinVar Annotator: match by term: Lung adenocarcinoma |
ClinVar |
PMID:22158538 PMID:23029227 PMID:23861105 PMID:24498085 PMID:26619011 |
|
NCBI chr20:9,742,904...9,753,840
Ensembl chr20:9,742,905...9,753,832
|
|
G |
Ubr5 |
ubiquitin protein ligase E3 component n-recognin 5 |
ameliorates |
ISO |
human cell line in a mouse model |
RGD |
PMID:32867711 |
RGD:151665200 |
NCBI chr 7:69,115,216...69,224,843
Ensembl chr 7:69,116,761...69,224,903
|
|
G |
Uck2 |
uridine-cytidine kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr13:79,380,807...79,438,121
Ensembl chr13:79,383,846...79,438,352
|
|
G |
Vav1 |
vav guanine nucleotide exchange factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27158780 |
|
NCBI chr 9:2,161,985...2,209,951
Ensembl chr 9:2,157,900...2,208,937
|
|
G |
Wrap53 |
WD repeat containing, antisense to TP53 |
severity |
ISO |
|
RGD |
PMID:28347242 |
RGD:21081522 |
NCBI chr10:54,282,092...54,299,908
Ensembl chr10:54,282,105...54,298,929
|
|
G |
Xpc |
XPC complex subunit, DNA damage recognition and repair factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21327329 PMID:27777383 |
|
NCBI chr 4:123,993,670...124,020,922
Ensembl chr 4:123,993,666...124,021,010
|
|
G |
Xpo1 |
exportin 1 |
exacerbates |
ISO |
circRNA:increased expression:lung (human) |
RGD |
PMID:33268793 |
RGD:151665799 |
NCBI chr14:97,233,282...97,275,536
Ensembl chr14:97,233,270...97,275,498
|
|
G |
Xrcc1 |
X-ray repair cross complementing 1 |
susceptibility severity |
ISO |
DNA:missense mutation:cds: p.R399Q (human) DNA:missense mutation:exon 10: p.R399Q (rs25487) (human) |
RGD |
PMID:11104903 PMID:20003463 |
RGD:151347406, RGD:151347422 |
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
|
|
G |
Xrcc5 |
X-ray repair cross complementing 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 9:73,955,216...74,044,020
Ensembl chr 9:73,955,216...74,044,018
|
|
G |
Xrcc6 |
X-ray repair cross complementing 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 7:113,542,992...113,563,762
Ensembl chr 7:113,543,057...113,563,762
|
|
G |
Zfhx3 |
zinc finger homeobox 3 |
ameliorates |
ISO |
DNA:mutations:multiple (human) |
RGD |
PMID:32653938 |
RGD:151361163 |
NCBI chr19:36,257,196...36,886,104
Ensembl chr19:36,630,254...36,881,771
|
|
|
G |
Arhgap44 |
Rho GTPase activating protein 44 |
|
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:28527113 |
RGD:401901290 |
NCBI chr10:49,655,583...49,822,876
Ensembl chr10:49,655,584...49,824,297
|
|
G |
Chrna5 |
cholinergic receptor nicotinic alpha 5 subunit |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:20124469 |
RGD:150527851 |
NCBI chr 8:55,369,794...55,398,526
Ensembl chr 8:55,369,794...55,398,146
|
|
G |
Dll4 |
delta like canonical Notch ligand 4 |
treatment |
IEP |
|
RGD |
PMID:33628824 |
RGD:155663482 |
NCBI chr 3:106,317,114...106,327,004
Ensembl chr 3:106,316,986...106,326,931
|
|
G |
Notch1 |
notch receptor 1 |
treatment |
IEP |
|
RGD |
PMID:33628824 |
RGD:155663482 |
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
|
|
G |
Ptpn13 |
protein tyrosine phosphatase, non-receptor type 13 |
|
ISO |
mRNA,protein:decreased expression:lung |
RGD |
PMID:22245727 |
RGD:152176663 |
NCBI chr14:6,108,202...6,282,619
Ensembl chr14:6,108,211...6,282,563
|
|
G |
Ttr |
transthyretin |
|
ISO |
protein:increased expression:lung (human) |
RGD |
PMID:26943652 |
RGD:151665207 |
NCBI chr18:11,941,791...11,951,008
Ensembl chr18:11,943,789...11,951,008
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
treatment |
ISO |
DNA:SNPs: :2677G>T, 3435C>T(human) ClinVar Annotator: match by term: Non-small cell lung cancer CTD Direct Evidence: marker/mechanism |
ClinVar CTD RGD |
PMID:10716719 PMID:11502320 PMID:12686700 PMID:15452305 PMID:15452306 PMID:15805193 PMID:17185560 PMID:20627363 PMID:22296372 PMID:25741868 PMID:17534875 More...
|
RGD:11080964 |
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
treatment |
ISO |
DNA:SNPs: :-24C>T, 3972C>T(human) |
RGD |
PMID:17534875 |
RGD:11080964 |
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abl1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
treatment |
ISO |
human cells in mouse model |
RGD |
PMID:26758680 |
RGD:126925226 |
NCBI chr 3:14,979,853...15,083,065
Ensembl chr 3:14,979,853...15,083,065
|
|
G |
Acvr1b |
activin A receptor type 1B |
susceptibility |
ISO |
DNA:SNP:intron:rs12809597(human) |
RGD |
PMID:22586632 |
RGD:151665491 |
NCBI chr 7:132,286,266...132,329,679
Ensembl chr 7:132,286,275...132,329,673
|
|
G |
Ada |
adenosine deaminase |
|
ISO |
protein:decreased expression:lymphocyte,erythrocyte: |
RGD |
PMID:31375946 |
RGD:152995295 |
NCBI chr 3:152,398,745...152,422,854
Ensembl chr 3:152,398,747...152,447,088
|
|
G |
Adam28 |
ADAM metallopeptidase domain 28 |
treatment |
ISO |
DNA:hypermethylation:promoter |
RGD |
PMID:22354764 PMID:21429053 |
RGD:153297789, RGD:153298914 |
NCBI chr15:43,774,463...43,840,726
Ensembl chr15:42,944,467...43,840,672
|
|
G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19027488 |
|
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
|
ISO |
mRNA, protein:decreased expression:lung (human) |
RGD |
PMID:15539404 |
RGD:7245515 |
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17094902 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
ameliorates treatment |
ISO |
ClinVar Annotator: match by term: Non-small cell lung cancer human cells in mouse model |
ClinVar RGD |
PMID:17611497 PMID:18256540 PMID:18392055 PMID:18504432 PMID:18611285 PMID:18954143 PMID:19418217 PMID:19487299 PMID:19853286 PMID:20233444 PMID:20453058 PMID:21464312 PMID:21512767 PMID:21793738 PMID:22538770 PMID:22610119 PMID:22722201 PMID:22722839 PMID:22980975 PMID:23237847 PMID:23348505 PMID:23700467 PMID:23728071 PMID:23934607 PMID:24190505 PMID:24657128 PMID:25157968 PMID:25741868 PMID:26619011 PMID:28492532 PMID:21277552 PMID:32276600 PMID:23632475 More...
|
RGD:5133243, RGD:151357000, RGD:150404268 |
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Akt2 |
AKT serine/threonine kinase 2 |
|
ISO |
ClinVar Annotator: match by term: Non-small cell lung carcinoma |
ClinVar |
PMID:21479466 PMID:25157968 PMID:28492532 |
|
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
|
|
G |
Akt3 |
AKT serine/threonine kinase 3 |
disease_progression |
ISO |
|
RGD |
PMID:19846969 |
RGD:13432583 |
NCBI chr13:88,943,708...89,225,831
Ensembl chr13:88,946,091...89,225,708
|
|
G |
Alb |
albumin |
disease_progression |
ISO |
|
RGD |
PMID:23778417 |
RGD:11036091 |
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Alk |
ALK receptor tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Non-small cell lung carcinoma |
CTD ClinVar |
PMID:17625570 PMID:18923525 PMID:20979469 PMID:20979473 PMID:21030459 PMID:21102269 PMID:21336183 PMID:21575866 PMID:21587085 PMID:21757253 PMID:21767331 PMID:21791641 PMID:21823889 PMID:21838707 PMID:21904575 PMID:21933749 PMID:21948233 PMID:22072639 PMID:22215748 PMID:22235099 PMID:22277784 PMID:22282074 PMID:22286583 PMID:22508824 PMID:22568572 PMID:22617245 PMID:22713522 PMID:22787409 PMID:22887466 PMID:22920921 PMID:22954507 PMID:22968692 PMID:22986231 PMID:23020724 PMID:23344087 PMID:23686600 PMID:24327273 PMID:24670165 PMID:25741868 More...
|
|
NCBI chr 6:22,879,653...23,599,636
Ensembl chr 6:22,880,625...23,598,034
|
|
G |
Amd1 |
adenosylmethionine decarboxylase 1 |
disease_progression |
ISO |
DNA:SNP: :rs1279590(human) |
RGD |
PMID:30650190 |
RGD:14390072 |
NCBI chr20:43,695,783...43,711,476
Ensembl chr20:43,697,237...43,711,476
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
ISO |
mRNA:decreased expression:lung |
RGD |
PMID:28982084 |
RGD:13703106 |
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18337602 |
|
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
|
|
G |
Araf |
A-Raf proto-oncogene, serine/threonine kinase |
|
ISO |
ClinVar Annotator: match by term: Non-small cell lung carcinoma |
ClinVar |
PMID:24569458 PMID:26619011 |
|
NCBI chr X:1,227,392...1,292,356
Ensembl chr X:1,227,392...1,239,073
|
|
G |
Areg |
amphiregulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15496427 PMID:16230376 |
|
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
|
|
G |
Arid1a |
AT-rich interaction domain 1A |
disease_progression treatment |
ISO |
protein:decreased expression:lung (human) DNA:mutations |
RGD |
PMID:24566899 PMID:32791957 |
RGD:126848781, RGD:126848874 |
NCBI chr 5:145,908,173...145,981,552
Ensembl chr 5:145,908,181...145,985,564
|
|
G |
Arid1b |
AT-rich interaction domain 1B |
treatment |
ISO |
DNA:mutations |
RGD |
PMID:32791957 |
RGD:126848874 |
NCBI chr 1:45,567,991...45,923,644
Ensembl chr 1:45,563,623...45,923,493
|
|
G |
Arpc5 |
actin related protein 2/3 complex, subunit 5 |
|
ISO |
mRNA:increased expression:lung (human) |
RGD |
PMID:22089643 |
RGD:11049488 |
NCBI chr13:64,904,504...64,913,413
Ensembl chr13:64,887,136...64,913,410
|
|
G |
Atf3 |
activating transcription factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17043644 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atm |
ATM serine/threonine kinase |
susceptibility treatment |
ISO |
DNA:SNPs,haplotypes:intron: (rs227060, rs170548) (human) human cells in mouse model |
RGD |
PMID:17582598 PMID:23632475 |
RGD:150383340, RGD:150404268 |
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Aven |
apoptosis and caspase activation inhibitor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15496427 |
|
NCBI chr 3:99,299,009...99,431,635
Ensembl chr 3:99,298,930...99,431,634
|
|
G |
Axin1 |
axin 1 |
disease_progression |
ISO |
protein:decreased expression:lung (human) |
RGD |
PMID:19735876 |
RGD:150530290 |
NCBI chr10:15,163,477...15,215,615
Ensembl chr10:15,163,684...15,215,615
|
|
G |
Axl |
Axl receptor tyrosine kinase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:22751098 |
|
NCBI chr 1:81,265,088...81,296,278
Ensembl chr 1:81,265,088...81,296,265
|
|
G |
Bad |
BCL2-associated agonist of cell death |
disease_progression |
ISO |
protein:decreased expression:lung |
RGD |
PMID:21918885 PMID:24092988 |
RGD:13432584, RGD:13434906 |
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bag6 |
BAG cochaperone 6 |
susceptibility |
ISO |
DNA:SNP: :rs3117582(human) |
RGD |
PMID:25884493 |
RGD:14390136 |
NCBI chr20:3,675,938...3,690,414
Ensembl chr20:3,675,938...3,688,657
|
|
G |
Bambi |
BMP and activin membrane-bound inhibitor |
|
ISO |
mRNA,protein:increased expression:lung: |
RGD |
PMID:20716422 |
RGD:14390157 |
NCBI chr17:54,121,251...54,125,816
Ensembl chr17:54,121,255...54,126,060
|
|
G |
Bard1 |
BRCA1 associated RING domain 1 |
disease_progression |
ISO |
|
RGD |
PMID:21815143 |
RGD:127229947 |
NCBI chr 9:72,616,070...72,694,553
Ensembl chr 9:72,623,155...72,694,265
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment |
ISO |
human cells in mouse model |
RGD |
PMID:23632475 |
RGD:150404268 |
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
treatment |
ISO |
human cells in mouse model |
RGD |
PMID:23632475 |
RGD:150404268 |
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bcl11a |
BCL11 transcription factor A |
severity |
ISO |
mRNA, protein:increased expression:lung (human) |
RGD |
PMID:23758992 |
RGD:11099968 |
NCBI chr14:98,029,018...98,124,181
Ensembl chr14:98,030,461...98,124,180
|
|
G |
Bcorl1 |
BCL6 co-repressor-like 1 |
severity |
ISO |
|
RGD |
PMID:26648304 |
RGD:11342082 |
NCBI chr X:127,516,504...127,584,529
Ensembl chr X:127,537,538...127,584,087
|
|
G |
Bend4 |
BEN domain containing 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28722770 |
|
NCBI chr14:40,753,048...40,788,686
Ensembl chr14:40,753,077...40,783,504
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
exacerbates |
ISO |
protein:increased expression:lung (human) |
RGD |
PMID:27737687 |
RGD:152998985 |
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
exacerbates ameliorates |
ISO |
protein:increased expression:lung (human) DNA:SNP:intron: (rs11225211) (human) |
RGD |
PMID:27737687 PMID:32905523 PMID:20959404 |
RGD:152998985, RGD:153297804, RGD:152999005 |
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16382892 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
|
ISO |
ClinVar Annotator: match by term: Non-small cell lung cancer | ClinVar Annotator: match by term: Non-small cell lung carcinoma |
ClinVar RGD |
PMID:2102266 PMID:12068308 PMID:12198537 PMID:12447372 PMID:12460918 PMID:12460919 PMID:12619120 PMID:12644542 PMID:12670889 PMID:12794760 PMID:12960123 PMID:14513361 PMID:14602780 PMID:14612909 PMID:14679157 PMID:14681681 PMID:14688025 PMID:15001635 PMID:15016963 PMID:15035987 PMID:15046639 PMID:15126572 PMID:15181070 PMID:15342696 PMID:15356022 PMID:15386408 PMID:15488754 PMID:15687339 PMID:15753399 PMID:15998781 PMID:16015629 PMID:16174717 PMID:16187918 PMID:16772349 PMID:17096326 PMID:17119447 PMID:17311103 PMID:17314276 PMID:17374713 PMID:17488796 PMID:17785355 PMID:18039235 PMID:18186519 PMID:18368129 PMID:18398503 PMID:18413255 PMID:18794803 PMID:19001320 PMID:19010912 PMID:19018267 PMID:19206169 PMID:19238210 PMID:19363522 PMID:19376813 PMID:19383316 PMID:19404918 PMID:19537845 PMID:19561230 PMID:19571295 PMID:19593635 PMID:19794125 PMID:19913317 PMID:20186801 PMID:20350999 PMID:20413299 PMID:20619739 PMID:20630094 PMID:20818844 PMID:20823850 PMID:20857202 PMID:21107320 PMID:21107323 PMID:21129611 PMID:21156289 PMID:21163703 PMID:21190184 PMID:21204800 PMID:21343559 PMID:21426297 PMID:21483012 PMID:21639808 PMID:21683865 PMID:21716161 PMID:21750866 PMID:21975775 PMID:22038996 PMID:22039425 PMID:22048237 PMID:22113612 PMID:22180495 PMID:22281684 PMID:22310681 PMID:22351686 PMID:22356324 PMID:22389471 PMID:22448344 PMID:22535154 PMID:22536370 PMID:22538770 PMID:22586120 PMID:22608338 PMID:22649091 PMID:22663011 PMID:22735384 PMID:22743296 PMID:22773810 PMID:22798288 PMID:22805292 PMID:22892241 PMID:22972589 PMID:22997239 PMID:23020132 PMID:23031422 PMID:23093928 PMID:23251002 PMID:23302800 PMID:23325582 PMID:23352452 PMID:23470635 PMID:23524406 PMID:23549875 PMID:23614898 PMID:23680146 PMID:23685455 PMID:23715574 PMID:23756559 PMID:23812671 PMID:23833300 PMID:23845441 PMID:23907581 PMID:23918947 PMID:24033266 PMID:24107445 PMID:24163374 PMID:24388723 PMID:24446311 PMID:24508103 PMID:24512911 PMID:24576830 PMID:24583796 PMID:24586605 PMID:24594804 PMID:24670642 PMID:24717435 PMID:25024077 PMID:25079330 PMID:25155755 PMID:25157968 PMID:25370471 PMID:25741868 PMID:25950823 PMID:25989278 PMID:26619011 PMID:26678033 PMID:28492532 PMID:28854169 PMID:29595366 PMID:29925953 PMID:31891627 PMID:32978145 PMID:33522658 PMID:34476331 PMID:21277552 PMID:20951313 More...
|
RGD:5133243, RGD:5133242 |
NCBI chr 4:68,375,484...68,510,652
Ensembl chr 4:68,384,649...68,510,463
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
disease_progression treatment |
ISO |
DNA:hypermethylation:promoter |
RGD |
PMID:23128816 PMID:23335114 PMID:24443257 PMID:21575522 |
RGD:126925968, RGD:127229949, RGD:127229948, RGD:127229935 |
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Brd7 |
bromodomain containing 7 |
disease_progression |
ISO |
protein:increased expression:lung: |
RGD |
PMID:22008115 |
RGD:9586442 |
NCBI chr19:18,708,792...18,737,497
Ensembl chr19:18,709,022...18,737,494
|
|
G |
Btk |
Bruton tyrosine kinase |
ameliorates |
ISO |
mRNA:increased expression:lung (human) |
RGD |
PMID:32623229 |
RGD:151347854 |
NCBI chr X:97,722,796...97,762,315
Ensembl chr X:97,722,802...97,761,853
|
|
G |
Calr |
calreticulin |
ameliorates |
ISO |
protein:increased expression:lung (human) mRNA, protein:increased expression:lung (human) |
RGD |
PMID:26842877 PMID:29228584 |
RGD:150521685, RGD:150521696 |
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
|
|
G |
Car12 |
carbonic anhydrase 12 |
disease_progression |
ISO |
|
RGD |
PMID:23910904 |
RGD:155226863 |
NCBI chr 8:67,274,739...67,330,428
Ensembl chr 8:67,274,359...67,330,440
|
|
G |
Car9 |
carbonic anhydrase 9 |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:30381462 PMID:23910904 |
RGD:155226863 |
NCBI chr 5:57,763,234...57,769,838
Ensembl chr 5:57,763,206...57,769,838
|
|
G |
Casp3 |
caspase 3 |
|
ISO |
DNA:SNP: :77G>A (human) mRNA:increased expression:lung |
RGD |
PMID:20661084 PMID:16231180 |
RGD:13434908, RGD:13434909 |
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp6 |
caspase 6 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:16231180 |
RGD:13434909 |
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
|
|
G |
Casp7 |
caspase 7 |
|
ISO |
DNA:SNP: :rs2227310 (human) |
RGD |
PMID:20661084 |
RGD:13434908 |
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20471133 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
no_association |
ISO |
DNA, mRNA:SNP, decreased expression:exon, lung:rs1052576 (human) mRNA:increased expression:lung mRNA:splice variant:lung DNA:SNP: :rs4645981 (human) DNA:SNP:exon:rs1052571 (human) |
RGD |
PMID:17285546 PMID:16231180 PMID:20972334 PMID:20661084 PMID:17285546 |
RGD:13434907, RGD:13434909, RGD:9999427, RGD:13434908, RGD:13434907 |
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11731445 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cbl |
Cbl proto-oncogene |
|
ISO |
DNA:missense mutations, loss of heterozygosity:multiple (human) |
RGD |
PMID:20126411 |
RGD:11576301 |
NCBI chr 8:44,487,824...44,571,620
Ensembl chr 8:44,489,410...44,571,176
|
|
G |
Cblb |
Cbl proto-oncogene B |
disease_progression treatment no_association |
ISO |
DNA:SNPs: :rs2305035, rs9657904 (human) DNA:SNP,haplotype: :rs2305035(human) DNA:SNPs: :rs3772534 (human) |
RGD |
PMID:29707316 PMID:26732495 PMID:29707316 |
RGD:126925239, RGD:150540334, RGD:126925239 |
NCBI chr11:48,589,878...48,756,940
Ensembl chr11:48,592,703...48,756,839
|
|
G |
Ccnb1 |
cyclin B1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34837450 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnd1 |
cyclin D1 |
disease_progression treatment |
ISO |
DNA:amplification mRNA:splice variant DNA:SNP: :870A>G (human) |
RGD |
PMID:26055143 PMID:9462706 PMID:18715616 PMID:16406195 |
RGD:11052612, RGD:13434928, RGD:13434926, RGD:13434924 |
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd2 |
cyclin D2 |
|
ISO |
mRNA:increased expression:lung protein:increased expression:lung |
RGD |
PMID:31253987 PMID:30227870 |
RGD:151665100, RGD:151665108 |
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
|
|
G |
Ccne1 |
cyclin E1 |
disease_progression |
ISO |
|
RGD |
PMID:11212263 |
RGD:13673913 |
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Ccnh |
cyclin H |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30705370 |
|
NCBI chr 2:15,835,064...15,855,648
Ensembl chr 2:15,834,833...15,855,819
|
|
G |
Cd74 |
CD74 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22919003 |
|
NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
|
|
G |
Cd9 |
CD9 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17043644 |
|
NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222
|
|
G |
Cda |
cytidine deaminase |
|
ISO |
DNA:snp:cds:p.K27Q (human) |
RGD |
PMID:18347182 |
RGD:2316365 |
NCBI chr 5:150,556,615...150,583,231
Ensembl chr 5:150,556,615...150,583,231
|
|
G |
Cdh13 |
cadherin 13 |
|
ISO |
DNA:hypermethylation:promoter CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:18337602 PMID:11389090 |
RGD:2293545 |
NCBI chr19:46,349,562...47,387,462
Ensembl chr19:46,349,430...47,387,459
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
disease_progression treatment |
ISO |
|
RGD |
PMID:24959380 PMID:24496383 |
RGD:13464275, RGD:13464276 |
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdk6 |
cyclin-dependent kinase 6 |
treatment |
ISO |
|
RGD |
PMID:27874949 PMID:23591808 |
RGD:13464321, RGD:13464324 |
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
treatment |
ISO |
human cells in mouse model |
RGD |
PMID:23632475 |
RGD:150404268 |
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
disease_progression |
ISO |
|
RGD |
PMID:9500468 |
RGD:13673920 |
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18337602 PMID:19375815 |
|
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B |
disease_progression |
ISO |
DNA:hypermethylation:promoter |
RGD |
PMID:11445839 |
RGD:13673922 |
NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050
|
|
G |
Cenpa |
centromere protein A |
severity |
ISO |
mRNA:increased expression:lung (human) |
RGD |
PMID:30008938 |
RGD:36947379 |
NCBI chr 6:25,700,142...25,711,767
Ensembl chr 6:25,700,142...25,711,675
|
|
G |
Cert1 |
ceramide transporter 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15496427 |
|
NCBI chr 2:27,882,546...27,987,090
Ensembl chr 2:27,882,555...27,987,074
|
|
G |
Chfr |
checkpoint with forkhead and ring finger domains |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20705357 |
|
NCBI chr12:46,504,497...46,538,104
Ensembl chr12:46,504,497...46,538,014
|
|
G |
Chga |
chromogranin A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21595568 |
|
NCBI chr 6:121,696,051...121,707,399
Ensembl chr 6:121,696,051...121,707,398
|
|
G |
Chi3l1 |
chitinase 3 like 1 |
severity |
ISO |
protein:increased secretion:serum (human) |
RGD |
PMID:20564116 |
RGD:4892660 |
NCBI chr13:45,641,802...45,649,787
Ensembl chr13:45,641,802...45,649,787
|
|
G |
Chrna3 |
cholinergic receptor nicotinic alpha 3 subunit |
disease_progression susceptibility |
ISO |
DNA:SNP: :rs6495309(human) DNA:SNP:exon: (rs1051730) (human) |
RGD |
PMID:22722785 PMID:21747048 |
RGD:151347532, RGD:151660346 |
NCBI chr 8:55,401,668...55,415,165
Ensembl chr 8:55,401,702...55,415,165
|
|
G |
Chrna5 |
cholinergic receptor nicotinic alpha 5 subunit |
disease_progression |
ISO |
DNA:SNP: :rs667282(human) |
RGD |
PMID:27050379 |
RGD:150527847 |
NCBI chr 8:55,369,794...55,398,526
Ensembl chr 8:55,369,794...55,398,146
|
|
G |
Chrna7 |
cholinergic receptor nicotinic alpha 7 subunit |
ameliorates |
ISO |
|
RGD |
PMID:19151195 PMID:19326440 |
RGD:151667906, RGD:151667908 |
NCBI chr 1:116,711,559...116,837,269
Ensembl chr 1:116,714,711...116,837,240
|
|
G |
Chrnb4 |
cholinergic receptor nicotinic beta 4 subunit |
severity |
ISO |
|
RGD |
PMID:25172267 |
RGD:151361147 |
NCBI chr 8:55,417,583...55,437,027
Ensembl chr 8:55,418,313...55,437,027
|
|
G |
Clptm1l |
CLPTM1-like |
disease_progression no_association |
ISO |
CTD Direct Evidence: marker/mechanism DNA:SNPs: :rs4975616,rs401681(human) DNA:SNP: :rs31490(human) DNA:SNPs:: rs401681,rs4975616(human) |
CTD RGD |
PMID:22675468 PMID:24679952 PMID:27982019 PMID:24175795 |
RGD:150530644, RGD:150530632, RGD:150530500 |
NCBI chr 1:29,667,545...29,683,530
Ensembl chr 1:29,667,545...29,683,530
|
|
G |
Cmpk1 |
cytidine/uridine monophosphate kinase 1 |
severity |
ISO |
DNA:snps:intron:IVS1+1057C>A rs4492666, IVS1-928C>A rs11211524 (human) |
RGD |
PMID:21642870 |
RGD:5133252 |
NCBI chr 5:128,480,301...128,507,830
Ensembl chr 5:128,480,301...128,507,830
|
|
G |
Col7a1 |
collagen type VII alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30381462 |
|
NCBI chr 8:109,604,877...109,637,249
Ensembl chr 8:109,604,861...109,637,252
|
|
G |
Coro1c |
coronin 1C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15496427 |
|
NCBI chr12:42,713,024...42,785,179
Ensembl chr12:42,712,991...42,785,179
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
ameliorates severity |
ISO |
human cells in a mouse model mRNA,protein:increased expression:lung (human) mRNA:decreased expression:lung (human) DNA:missense mutation:CDS:p.H362R (rs10079250) (human) |
RGD |
PMID:27486763 PMID:33428598 PMID:24451080 PMID:28449811 |
RGD:150524288, RGD:150524295, RGD:150524294, RGD:150524292 |
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
|
|
G |
Csf3 |
colony stimulating factor 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:7692001 |
|
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
|
|
G |
Cst6 |
cystatin E/M |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17043644 |
|
NCBI chr 1:202,655,322...202,657,030
Ensembl chr 1:202,655,322...202,657,030
|
|
G |
Ctdspl |
CTD small phosphatase like |
|
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:22491060 |
RGD:153350086 |
NCBI chr 8:118,642,729...118,767,238
Ensembl chr 8:118,642,672...118,767,117
|
|
G |
Cux1 |
cut-like homeobox 1 |
exacerbates |
ISO |
mRNA:increased expression:lung (human) |
RGD |
PMID:28405678 |
RGD:152985544 |
NCBI chr12:20,107,062...20,425,868
Ensembl chr12:20,107,311...20,425,866 Ensembl chr 4:20,107,311...20,425,866
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
disease_progression |
ISO |
protein:increased expression:lung (human) |
RGD |
PMID:22977534 |
RGD:152023747 |
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cycs |
cytochrome c, somatic |
severity treatment |
ISO |
protein:decreased expression:serum |
RGD |
PMID:25578497 PMID:25578497 |
RGD:13792769, RGD:13792769 |
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyld |
CYLD lysine 63 deubiquitinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17043644 |
|
NCBI chr19:18,310,632...18,373,696
Ensembl chr19:18,314,019...18,373,658
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
exacerbates susceptibility disease_progression |
ISO |
mRNA:increased expression:lung (human) DNA:SNPs:multiple (human) DNA:SNPs:CDS, 3' utr: (rs6068816, rs4809957) (human) DNA:SNP:exon, intron: (rs6068816, rs2181874) (human) DNA:SNP:intron 4: (rs3787554) (human) |
RGD |
PMID:29250167 PMID:29726119 PMID:17671213 PMID:25544771 PMID:27669215 PMID:21169243 PMID:23435876 More...
|
RGD:151361179, RGD:151708739, RGD:151708738, RGD:151665789, RGD:151665175, RGD:151361185, RGD:151361182 |
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16142352 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Dab2ip |
DAB2 interacting protein |
disease_progression |
ISO |
protein:decreased expression:lung (human) |
RGD |
PMID:31849482 |
RGD:151665206 |
NCBI chr 3:18,915,290...19,086,282
Ensembl chr 3:18,915,290...19,086,280
|
|
G |
Dapk1 |
death associated protein kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11313923 |
|
NCBI chr17:3,930,223...4,090,991
Ensembl chr17:3,930,213...4,090,991
|
|
G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
disease_progression |
ISO |
|
RGD |
PMID:17299390 |
RGD:150429714 |
NCBI chr20:3,042,494...3,064,442
Ensembl chr20:3,044,320...3,064,468
|
|
G |
Ddr2 |
discoidin domain receptor tyrosine kinase 2 |
|
ISO |
mRNA:decreased expression:lung ClinVar Annotator: match by term: Non-small cell lung carcinoma |
ClinVar RGD |
PMID:18938156 PMID:22328973 PMID:23932362 PMID:25741868 PMID:26206333 PMID:28492532 PMID:17299390 More...
|
RGD:150429714 |
NCBI chr13:82,193,623...82,318,229
Ensembl chr13:82,195,463...82,317,363
|
|
G |
Deup1 |
deuterosome assembly protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30705370 |
|
NCBI chr 8:12,380,300...12,442,649
Ensembl chr 8:12,380,302...12,442,199
|
|
G |
Diablo |
diablo, IAP-binding mitochondrial protein |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:16231180 |
RGD:13434909 |
NCBI chr12:33,055,784...33,070,401
Ensembl chr12:33,055,263...33,070,387
|
|
G |
Dnai7 |
dynein axonemal intermediate chain 7 |
ameliorates |
ISO |
|
RGD |
PMID:24860162 |
RGD:152998908 |
NCBI chr 4:178,143,499...178,179,871
Ensembl chr 4:178,143,500...178,179,980
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
treatment |
ISO |
|
RGD |
PMID:32211850 PMID:32211850 |
RGD:126848780, RGD:126848780 |
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Dusp3 |
dual specificity phosphatase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15496427 |
|
NCBI chr10:86,920,014...86,933,739
Ensembl chr10:86,920,014...86,933,962
|
|
G |
E2f1 |
E2F transcription factor 1 |
treatment disease_progression severity |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:29754146 PMID:28498400 PMID:12358350 PMID:12237873 PMID:23543735 |
RGD:13464333, RGD:13464343, RGD:13464342, RGD:9590260 |
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
E2f2 |
E2F transcription factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29754146 |
|
NCBI chr 5:148,399,193...148,422,595
Ensembl chr 5:148,399,642...148,421,217
|
|
G |
E2f3 |
E2F transcription factor 3 |
disease_progression |
ISO |
DNA:SNP: :rs3806116 (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:29754146 PMID:27557513 |
RGD:13464345 |
NCBI chr17:34,601,756...34,679,139
Ensembl chr17:34,601,830...34,676,253
|
|
G |
E2f5 |
E2F transcription factor 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29754146 |
|
NCBI chr 2:86,997,331...87,012,908
Ensembl chr 2:86,997,332...87,012,990
|
|
G |
E2f6 |
E2F transcription factor 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29754146 |
|
NCBI chr 6:39,592,224...39,608,685
Ensembl chr 6:39,592,228...39,608,683
|
|
G |
E2f7 |
E2F transcription factor 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29754146 |
|
NCBI chr 7:46,150,533...46,192,739
Ensembl chr 7:46,151,293...46,192,734
|
|
G |
E2f8 |
E2F transcription factor 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29754146 |
|
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
|
|
G |
Eef2 |
eukaryotic translation elongation factor 2 |
disease_progression |
ISO |
protein:increased expression:blood serum (human) |
RGD |
PMID:24377563 |
RGD:153298905 |
NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
|
|
G |
Egf |
epidermal growth factor |
treatment |
ISO |
|
RGD |
PMID:26927662 PMID:25992884 |
RGD:13464348, RGD:13464350 |
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egfr |
epidermal growth factor receptor |
ameliorates severity treatment susceptibility |
ISO |
ClinVar Annotator: match by term: Non-small cell lung cancer | ClinVar Annotator: match by term: Non-small cell lung carcinoma | ClinVar Annotator: match by term: Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, somatic human cells in mouse model CTD Direct Evidence: marker/mechanism protein:decreased expression:tumor (human) DNA:deletion:cds:2240del18 (human) |
ClinVar CTD RGD |
PMID:2302402 PMID:11423618 PMID:15118073 PMID:15118125 PMID:15272417 PMID:15329413 PMID:15604253 PMID:15623594 PMID:15625347 PMID:15681531 PMID:15710947 PMID:15728811 PMID:15737014 PMID:15738541 PMID:15741570 PMID:15788655 PMID:15897572 PMID:15901872 PMID:15998907 PMID:16011858 PMID:16105816 PMID:16115929 PMID:16187797 PMID:16199108 PMID:16203769 PMID:16204011 PMID:16204070 PMID:16205628 PMID:16258541 PMID:16467085 PMID:16533793 PMID:16707764 PMID:16730855 PMID:16863509 PMID:16865253 PMID:16912157 PMID:16956694 PMID:17020982 PMID:17047654 PMID:17085664 PMID:17106442 PMID:17192902 PMID:17285735 PMID:17317677 PMID:17332364 PMID:17387341 PMID:17429313 PMID:17473653 PMID:17473659 PMID:17510392 PMID:17545553 PMID:17653080 PMID:17726540 PMID:17904685 PMID:18089823 PMID:18093943 PMID:18176089 PMID:18199554 PMID:18227510 PMID:18303429 PMID:18325048 PMID:18334834 PMID:18372921 PMID:18450321 PMID:18458038 PMID:18596266 PMID:18628075 PMID:18948947 PMID:18981003 PMID:18992959 PMID:19096302 PMID:19096324 PMID:19147750 PMID:19381876 PMID:19455431 PMID:19536777 PMID:19589612 PMID:19671738 PMID:19692680 PMID:19692684 PMID:19922469 PMID:20022809 PMID:20033049 PMID:20038723 PMID:20068085 PMID:20129249 PMID:20479403 PMID:20522446 PMID:20559149 PMID:20573926 PMID:20808254 PMID:21057810 PMID:21194487 PMID:21233402 PMID:21248300 PMID:21252721 PMID:21317742 PMID:21336183 PMID:21430269 PMID:21440325 PMID:21478906 PMID:21527506 PMID:21531810 PMID:21572125 PMID:21592614 PMID:21670455 PMID:21718596 PMID:21777763 PMID:21782507 PMID:21783417 PMID:21791641 PMID:21841502 PMID:21899495 PMID:21900837 PMID:21904575 PMID:21921847 PMID:21933749 PMID:22019513 PMID:22215752 PMID:22285168 PMID:22286583 PMID:22370314 PMID:22452895 PMID:22452896 PMID:22588155 PMID:22617245 PMID:22622260 PMID:22751098 PMID:22753918 PMID:22760226 PMID:22787409 PMID:22787412 PMID:22809298 PMID:22948846 PMID:22992668 PMID:23102728 PMID:23242437 PMID:23435014 PMID:23468066 PMID:23485129 PMID:23540867 PMID:23800712 PMID:23816960 PMID:23816963 PMID:23945392 PMID:23948351 PMID:24033266 PMID:24039832 PMID:24065731 PMID:24202392 PMID:24453288 PMID:24467950 PMID:24478319 PMID:24623981 PMID:24636847 PMID:24658966 PMID:24712396 PMID:24729716 PMID:24736066 PMID:24736080 PMID:24893891 PMID:24894453 PMID:24934779 PMID:25061320 PMID:25157968 PMID:25521405 PMID:25668228 PMID:25741868 PMID:25923549 PMID:25923550 PMID:25939061 PMID:25948633 PMID:26051236 PMID:26490356 PMID:26515464 PMID:26619011 PMID:26700910 PMID:26720284 PMID:27294619 PMID:27993330 PMID:28492532 PMID:28947568 PMID:29100434 PMID:29141884 PMID:30610926 PMID:31396478 PMID:33858029 PMID:20951313 PMID:31205511 PMID:32276600 PMID:11789762 PMID:27040853 PMID:21439671 PMID:21124077 PMID:15118073 PMID:20519133 More...
|
RGD:5133242, RGD:153344584, RGD:151357000, RGD:126790479, RGD:13464349, RGD:5131629, RGD:5131640, RGD:1601010, RGD:5133241 |
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egr1 |
early growth response 1 |
resistance |
ISO |
mRNA:increased expression:tumor (human) |
RGD |
PMID:15774784 |
RGD:5131925 |
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
treatment |
ISO |
human cells in mouse model |
RGD |
PMID:23632475 |
RGD:150404268 |
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Eml4 |
EMAP like 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17625570 PMID:21757253 PMID:21767331 PMID:22568572 PMID:22617245 PMID:22986231 More...
|
|
NCBI chr 6:11,219,545...11,334,824
Ensembl chr 6:11,219,566...11,334,879
|
|
G |
Eno1 |
enolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17094902 |
|
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336 Ensembl chr 3:160,719,951...160,731,336
|
|
G |
Eno2 |
enolase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21595568 |
|
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
treatment |
ISO |
|
RGD |
PMID:21812995 |
RGD:10395382 |
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
disease_progression |
ISO |
|
RGD |
PMID:17273734 |
RGD:4889124 |
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
|
ISO |
ClinVar Annotator: match by term: Non-small cell lung carcinoma |
ClinVar RGD |
PMID:15457249 PMID:15753357 PMID:16638863 PMID:16863509 PMID:18334834 PMID:22325357 PMID:22761469 PMID:24033266 PMID:25157968 PMID:21277552 More...
|
RGD:5133243 |
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
treatment disease_progression |
ISO |
|
RGD |
PMID:20364069 PMID:11789762 |
RGD:126790478, RGD:126790479 |
NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
treatment disease_progression severity |
ISO |
CTD Direct Evidence: marker/mechanism DNA:SNPs:multiple (human) DNA:silent mutation:cds:p.N118N (human) protein:decreased expression:lung (human) |
CTD RGD |
PMID:21553054 PMID:23912706 PMID:28924235 PMID:23549037 PMID:24443257 PMID:15140544 PMID:16957145 More...
|
RGD:153323316, RGD:127229950, RGD:127229948, RGD:13207428, RGD:13207308 |
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
|
|
G |
Ercc2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
disease_progression treatment |
ISO |
DNA:polymorphism:cds:p.K751Q(human) DNA:SNPs:multiple (human) ClinVar Annotator: match by term: Non-small cell lung carcinoma |
ClinVar RGD |
PMID:19434073 PMID:19470925 PMID:24033266 PMID:24728327 PMID:25741868 PMID:28492532 PMID:25596702 PMID:28924235 More...
|
RGD:12880391, RGD:153323316 |
NCBI chr 1:79,033,342...79,047,102
Ensembl chr 1:79,033,326...79,047,102
|
|
G |
Ercc3 |
ERCC excision repair 3, TFIIH core complex helicase subunit |
treatment |
ISO |
DNA:snp:intron:c.2064+741T>C (rs3738948) (human) |
RGD |
PMID:25069034 |
RGD:11098167 |
NCBI chr18:23,883,613...23,914,326
Ensembl chr18:23,883,580...23,914,329
|
|
G |
Ercc5 |
ERCC excision repair 5, endonuclease |
treatment |
ISO |
DNA:SNPs:multiple (human) |
RGD |
PMID:24782167 PMID:28924235 |
RGD:151347410, RGD:153323316 |
NCBI chr 9:46,309,477...46,354,478
Ensembl chr 9:46,309,389...46,354,472
|
|
G |
Ercc6 |
ERCC excision repair 6, chromatin remodeling factor |
treatment |
ISO |
DNA:SNP:intron: (rs4253002) (human) |
RGD |
PMID:28924235 |
RGD:153323316 |
NCBI chr16:7,764,983...7,835,587
Ensembl chr16:7,765,013...7,835,587
|
|
G |
Ergic3 |
ERGIC and golgi 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27588471 |
|
NCBI chr 3:144,525,059...144,534,813
Ensembl chr 3:144,525,092...144,534,813
|
|
G |
Esr1 |
estrogen receptor 1 |
|
ISO |
DNA:hypermethylation: :lung |
RGD |
PMID:19506903 |
RGD:4892255 |
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
disease_progression |
ISO |
|
RGD |
PMID:21539681 PMID:23300840 |
RGD:126781700, RGD:126781715 |
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
|
|
G |
Fap |
fibroblast activation protein, alpha |
disease_progression |
ISO |
|
RGD |
PMID:29415055 |
RGD:152600902 |
NCBI chr 3:47,138,823...47,207,671
Ensembl chr 3:47,138,813...47,225,545
|
|
G |
Faslg |
Fas ligand |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21807637 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fat1 |
FAT atypical cadherin 1 |
treatment |
ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:34390292 PMID:31085721 |
RGD:151347689 |
NCBI chr16:47,177,253...47,296,261
Ensembl chr16:47,177,248...47,296,107
|
|
G |
Fbxo11 |
F-box protein 11 |
treatment |
ISO |
|
RGD |
PMID:31778188 |
RGD:152025265 |
NCBI chr 6:6,486,761...6,562,664
Ensembl chr 6:6,486,015...6,562,662
|
|
G |
Fgf9 |
fibroblast growth factor 9 |
severity |
ISO |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:lung (human) |
CTD RGD |
PMID:19358281 PMID:24239165 PMID:31884893 |
RGD:152177524, RGD:152177912 |
NCBI chr15:32,208,993...32,254,952
Ensembl chr15:32,210,074...32,253,309
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:22286583 PMID:27794399 PMID:23806793 |
RGD:25330355 |
NCBI chr16:66,491,930...66,547,161
Ensembl chr16:66,494,042...66,547,350
|
|
G |
Fgfr4 |
fibroblast growth factor receptor 4 |
disease_progression severity |
ISO |
mRNA, protein:increased expression:lung (human) DNA:SNP:exon 9: p.G3888R (rs351855) (human) |
RGD |
PMID:26045670 PMID:23524567 |
RGD:150429970, RGD:150429982 |
NCBI chr17:9,461,541...9,476,268
Ensembl chr17:9,461,547...9,476,242
|
|
G |
Fh |
fumarate hydratase |
severity |
ISO |
DNA:SNP: (rs1414493) (human) |
RGD |
PMID:25576295 |
RGD:150340558 |
NCBI chr13:87,524,331...87,550,215
Ensembl chr13:87,524,337...87,550,266
|
|
G |
Fhit |
fragile histidine triad diadenosine triphosphatase |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism DNA:loss of heterozygosity:intron: |
CTD RGD |
PMID:11788890 PMID:9635574 PMID:9850082 |
RGD:13792815, RGD:13792770 |
NCBI chr15:13,935,029...15,442,620
Ensembl chr15:13,934,995...15,442,340
|
|
G |
Fosl2 |
FOS like 2, AP-1 transcription factor subunit |
disease_progression |
ISO |
protein:increased expression:lung (human) |
RGD |
PMID:25375657 |
RGD:11074609 |
NCBI chr 6:24,297,898...24,319,219
Ensembl chr 6:24,300,956...24,320,034
|
|
G |
Foxa1 |
forkhead box A1 |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:lung |
CTD RGD |
PMID:32717239 PMID:26658322 PMID:26909612 |
RGD:11554787, RGD:151665747 |
NCBI chr 6:75,099,907...75,136,534
Ensembl chr 6:75,103,503...75,136,188
|
|
G |
Foxa2 |
forkhead box A2 |
|
ISO |
mRNA:decreased expression:lung |
RGD |
PMID:26658322 |
RGD:11554787 |
NCBI chr 3:135,470,123...135,474,326
Ensembl chr 3:135,470,131...135,474,326
|
|
G |
Foxl2 |
forkhead box L2 |
|
ISO |
DNA:hypermethylation: (human) |
RGD |
PMID:23599765 |
RGD:13503323 |
NCBI chr 8:99,512,971...99,514,500
Ensembl chr 8:99,513,303...99,514,427
|
|
G |
Foxm1 |
forkhead box M1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18345025 PMID:19672312 |
|
NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684
|
|
G |
Foxo3 |
forkhead box O3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19380174 |
|
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
|
|
G |
Foxp1 |
forkhead box P1 |
|
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:22491060 |
RGD:153350086 |
NCBI chr 4:131,559,599...132,155,092
Ensembl chr 4:131,564,756...132,112,258
|
|
G |
Frzb |
frizzled-related protein |
|
ISO |
DNA:hypermethylation:exon 1 |
RGD |
PMID:27623992 |
RGD:32716395 |
NCBI chr 3:65,332,274...65,365,208
Ensembl chr 3:65,332,277...65,365,208
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15496427 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gipr |
gastric inhibitory polypeptide receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17094902 |
|
NCBI chr 1:78,804,287...78,814,462
Ensembl chr 1:78,805,593...78,814,462
|
|
G |
Gnaq |
G protein subunit alpha q |
disease_progression |
ISO |
|
RGD |
PMID:24518087 |
RGD:126781753 |
NCBI chr 1:213,425,631...213,671,947
Ensembl chr 1:213,424,465...213,667,672
|
|
G |
Gpr135 |
G protein-coupled receptor 135 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28722770 |
|
NCBI chr 6:90,627,533...90,630,661
Ensembl chr 6:90,629,178...90,630,551
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
treatment onset |
ISO |
DNA:SNP: (human) mRNA:increased expression:leukocyte (human) |
RGD |
PMID:19347979 PMID:33474835 |
RGD:152998881, RGD:152998904 |
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Grik2 |
glutamate ionotropic receptor kainate type subunit 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30705370 |
|
NCBI chr20:52,135,325...52,833,061
Ensembl chr20:52,133,851...52,838,375
|
|
G |
Grp |
gastrin releasing peptide |
disease_progression |
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:30146822 |
RGD:401700396 |
NCBI chr18:59,388,679...59,402,061
Ensembl chr18:59,388,274...59,402,061
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19900515 |
|
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
susceptibility |
ISO |
DNA:SNP: :p.A114V (human) CTD Direct Evidence: marker/mechanism DNA:polymorphism:exon:p.I105V (human) |
CTD RGD |
PMID:17094902 PMID:18258609 PMID:19174490 |
RGD:4140950, RGD:4140944 |
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
H19 |
H19 imprinted maternally expressed transcript |
disease_progression |
ISO |
mRNA:increased expression:lung (human) |
RGD |
PMID:30280776 |
RGD:126925764 |
NCBI chr 1:197,730,698...197,733,374
Ensembl chr 1:197,730,698...197,733,134
|
|
G |
Hdac3 |
histone deacetylase 3 |
|
ISO |
|
RGD |
PMID:24482232 |
RGD:9588265 |
NCBI chr18:29,770,637...29,789,850
Ensembl chr18:29,770,636...29,793,856
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21994468 |
|
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:30381462 PMID:21812995 |
RGD:10395382 |
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
|
ISO |
protein:increased expression:lung (human) |
RGD |
PMID:20716340 |
RGD:9999189 |
NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609
|
|
G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
susceptibility |
ISO |
antibody 703D4 recognizes Hnrnpa2b1 protein (RGD:9685415);protein:increased expression:sputum (human) |
RGD |
PMID:2846790 |
RGD:9685413 |
NCBI chr 4:80,534,659...80,545,297
Ensembl chr 4:80,534,651...80,545,249
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
|
ISO |
ClinVar Annotator: match by term: Non-small cell lung carcinoma |
ClinVar |
PMID:2674130 PMID:3004741 PMID:3283542 PMID:3304147 PMID:6287572 PMID:6287573 PMID:6288698 PMID:10716188 PMID:21779495 PMID:24033266 PMID:25741868 PMID:28492532 PMID:29493581 More...
|
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Hs3st2 |
heparan sulfate-glucosamine 3-sulfotransferase 2 |
|
ISO |
DNA:hypermethylation |
RGD |
PMID:27777637 |
RGD:152998954 |
NCBI chr 1:175,956,161...176,077,400
Ensembl chr 1:175,956,157...176,077,399
|
|
G |
Htra1 |
HtrA serine peptidase 1 |
exacerbates |
ISO |
protein:decreased expression:lung (human) |
RGD |
PMID:32878625 |
RGD:152975629 |
NCBI chr 1:185,497,815...185,547,380
Ensembl chr 1:185,497,735...185,547,379
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
disease_progression |
ISO |
progression-free survival; protein:increased secretion:serum (human) |
RGD |
PMID:19949019 |
RGD:4145465 |
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
severity |
ISO |
DNA:SNP: (rs11540478) (human) |
RGD |
PMID:25576295 |
RGD:150340558 |
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
|
|
G |
Ikzf2 |
IKAROS family zinc finger 2 |
exacerbates |
ISO |
protein:decreased expression:venous blood, lung, regulatory T cell (human) |
RGD |
PMID:26460798 |
RGD:151347635 |
NCBI chr 9:71,046,038...71,191,296
Ensembl chr 9:71,042,440...71,190,867
|
|
G |
Ikzf3 |
IKAROS family zinc finger 3 |
exacerbates |
ISO |
protein:increased expression:lung (human) |
RGD |
PMID:24823637 |
RGD:151347636 |
NCBI chr10:83,460,564...83,553,591
Ensembl chr10:83,465,745...83,553,591
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20471133 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il18 |
interleukin 18 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:15955140 |
RGD:4889836 |
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
DNA:SNPs: : |
RGD |
PMID:19505916 |
RGD:4142793 |
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
susceptibility |
ISO |
DNA:polymorphism: :-31T>C (human) |
RGD |
PMID:16126303 |
RGD:4143167 |
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
susceptibility |
ISO |
DNA:polymorphism (human) |
RGD |
PMID:16126303 |
RGD:4143167 |
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Il6r |
interleukin 6 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22552503 |
|
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
|
|
G |
Il7 |
interleukin 7 |
disease_progression |
ISO |
|
RGD |
PMID:21159243 |
RGD:151347686 |
NCBI chr 2:94,235,219...94,280,075
Ensembl chr 2:94,234,766...94,280,075
|
|
G |
Il7r |
interleukin 7 receptor |
disease_progression susceptibility |
ISO |
DNA:SNPs:: rs1494555,rs7737000(human) |
RGD |
PMID:21159243 PMID:19505916 |
RGD:151347686, RGD:4142793 |
NCBI chr 2:58,452,393...58,477,757
Ensembl chr 2:58,454,217...58,477,757
|
|
G |
Iqsec1 |
IQ motif and Sec7 domain ArfGEF 1 |
|
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:22491060 |
RGD:153350086 |
NCBI chr 4:123,168,719...123,488,300
Ensembl chr 4:123,168,719...123,488,172
|
|
G |
Irf1 |
interferon regulatory factor 1 |
|
ISO |
ClinVar Annotator: match by term: Non-small cell lung carcinoma |
ClinVar RGD |
PMID:10395927 PMID:10395927 |
RGD:1600014 |
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
|
|
G |
Irs4 |
insulin receptor substrate 4 |
|
ISO |
protein:increased expression:lung (human) |
RGD |
PMID:33894221 |
RGD:151347872 |
NCBI chr X:105,344,020...105,360,004
|
|
G |
Itga9 |
integrin subunit alpha 9 |
|
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:22491060 |
RGD:153350086 |
NCBI chr 8:118,307,424...118,615,527
Ensembl chr 8:118,307,381...118,613,754
|
|
G |
Itgb1 |
integrin subunit beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:lung |
CTD RGD |
PMID:21478906 PMID:28537888 |
RGD:13792830 |
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
|
|
G |
Itgb3 |
integrin subunit beta 3 |
|
ISO |
|
RGD |
PMID:19386436 |
RGD:5037228 |
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
|
|
G |
Itgb4 |
integrin subunit beta 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27107458 |
|
NCBI chr10:101,206,657...101,243,012
Ensembl chr10:101,206,665...101,243,012
|
|
G |
Jak1 |
Janus kinase 1 |
disease_progression |
ISO |
protein:increased phosphorylation:lung |
RGD |
PMID:28989534 |
RGD:150524360 |
NCBI chr 5:115,780,248...115,888,841
Ensembl chr 5:115,780,248...115,888,926
|
|
G |
Jak2 |
Janus kinase 2 |
treatment |
ISO |
human cells in mouse model |
RGD |
PMID:25869210 PMID:21325979 |
RGD:149735332, RGD:149735342 |
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
severity |
ISO |
RNA:increased expression:lung (human) |
RGD |
PMID:29895215 |
RGD:151347665 |
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Kat2a |
lysine acetyltransferase 2A |
disease_progression |
ISO |
|
RGD |
PMID:23543735 |
RGD:9590260 |
NCBI chr10:85,632,216...85,640,561
Ensembl chr10:85,632,216...85,640,166
|
|
G |
Kdm1a |
lysine demethylase 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22493729 |
|
NCBI chr 5:148,782,976...148,838,319
Ensembl chr 5:148,782,976...148,838,319
|
|
G |
Kdm2a |
lysine demethylase 2A |
severity |
ISO |
mRNA:increased expression:stomach (human) human gene in a mouse model |
RGD |
PMID:24200691 PMID:24482232 |
RGD:9588263, RGD:9588265 |
NCBI chr 1:201,612,427...201,682,359
Ensembl chr 1:201,612,453...201,680,787
|
|
G |
Kdm3b |
lysine demethylase 3B |
|
ISO |
DNA:amplification:lung, peripheral blood mononuclear cell (human) |
RGD |
PMID:18975135 |
RGD:9586737 |
NCBI chr18:26,380,859...26,436,701
Ensembl chr18:26,380,964...26,436,628
|
|
G |
Kdm5a |
lysine demethylase 5A |
severity |
ISO |
protein:increased expression:lung (human) |
RGD |
PMID:25162518 |
RGD:9588530 |
NCBI chr 4:153,565,909...153,643,912
Ensembl chr 4:153,565,846...153,642,422
|
|
G |
Kdm6a |
lysine demethylase 6A |
exacerbates |
ISO |
human cells in a mouse model |
RGD |
PMID:32879445 |
RGD:150429731 |
NCBI chr X:4,337,466...4,477,100
Ensembl chr X:4,337,750...4,477,062
|
|
G |
Kdr |
kinase insert domain receptor |
disease_progression treatment |
ISO |
DNA:CNVs protein:increased expression:plasma DNA:SNP:promoter:���906T>C (rs2071559) (human) DNA, protein:CNVs, increased expression:lung |
RGD |
PMID:21724587 PMID:21481963 PMID:25975224 PMID:12415261 PMID:16697074 PMID:25561764 More...
|
RGD:126908001, RGD:126925199, RGD:126925198, RGD:126925192, RGD:126925189, RGD:126925188 |
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22684020 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Kif5b |
kinesin family member 5B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21757253 |
|
NCBI chr17:51,489,904...51,527,508
Ensembl chr17:51,489,944...51,527,508
|
|
G |
Kit |
KIT proto-oncogene receptor tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Non-small cell lung carcinoma |
CTD ClinVar |
PMID:7530509 PMID:9438854 PMID:11276010 PMID:15790786 PMID:16731599 PMID:16908931 PMID:17372901 PMID:18448188 PMID:18980976 PMID:19671763 PMID:19996579 PMID:21642685 PMID:21690468 PMID:22261812 PMID:22357254 PMID:23598963 PMID:24688052 PMID:25157968 PMID:27771813 PMID:27981619 PMID:28492532 More...
|
|
NCBI chr14:32,547,459...32,624,694
Ensembl chr14:32,548,877...32,624,652
|
|
G |
Kmt2c |
lysine methyltransferase 2C |
disease_progression |
ISO |
|
RGD |
PMID:33665490 |
RGD:150523771 |
NCBI chr 4:9,620,638...9,834,787
Ensembl chr 4:9,609,627...9,833,539
|
|
G |
Kmt2d |
lysine methyltransferase 2D |
disease_progression |
ISO |
DNA, protein:missense mutations, nonsense mutations, frameshift mutation, increased expression:lung |
RGD |
PMID:29627316 PMID:33665490 PMID:25112956 |
RGD:150523767, RGD:150523771, RGD:150523769 |
NCBI chr 7:129,980,744...130,022,088
Ensembl chr 7:129,962,887...130,020,325
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
|
ISO |
ClinVar Annotator: match by term: Non-small cell lung cancer | ClinVar Annotator: match by term: Non-small cell lung carcinoma CTD Direct Evidence: marker/mechanism |
ClinVar CTD RGD |
PMID:2278970 PMID:2547513 PMID:3122217 PMID:3627975 PMID:6320174 PMID:6695174 PMID:7773929 PMID:8439212 PMID:11745231 PMID:12460918 PMID:12720172 PMID:15093544 PMID:15696205 PMID:15842656 PMID:16051643 PMID:16247081 PMID:16361624 PMID:16434492 PMID:16474404 PMID:16618717 PMID:17062680 PMID:17332249 PMID:17384584 PMID:17704260 PMID:17910045 PMID:18316791 PMID:18594010 PMID:18794081 PMID:19018267 PMID:19029981 PMID:19047918 PMID:19075190 PMID:19114683 PMID:19255327 PMID:19349489 PMID:19358724 PMID:19396835 PMID:19679400 PMID:19773371 PMID:19794967 PMID:19881948 PMID:20526288 PMID:20609353 PMID:20805368 PMID:20921462 PMID:20921465 PMID:20926413 PMID:20949522 PMID:20949621 PMID:20978259 PMID:21044336 PMID:21063026 PMID:21079152 PMID:21169357 PMID:21228335 PMID:21336183 PMID:21398618 PMID:21975775 PMID:22025163 PMID:22235099 PMID:22282465 PMID:22392911 PMID:22407852 PMID:22499344 PMID:22571758 PMID:22617245 PMID:22683711 PMID:22722830 PMID:22734028 PMID:22787409 PMID:22887466 PMID:22897852 PMID:23014527 PMID:23096712 PMID:23182985 PMID:23255105 PMID:23325582 PMID:23406027 PMID:23435014 PMID:23548132 PMID:24033266 PMID:24138715 PMID:24382853 PMID:24558511 PMID:24628546 PMID:24688052 PMID:24720724 PMID:24836576 PMID:25044103 PMID:25157968 PMID:25695684 PMID:25705018 PMID:25741868 PMID:25808193 PMID:26242988 PMID:26372703 PMID:26521233 PMID:26619011 PMID:26623049 PMID:26970110 PMID:26985062 PMID:27577878 PMID:27588471 PMID:28492532 PMID:29298116 PMID:29493581 PMID:30443000 PMID:30448735 PMID:30732632 PMID:30891959 PMID:31666701 PMID:31891627 PMID:32581362 PMID:35658005 PMID:35794233 PMID:20951313 More...
|
RGD:5133242 |
NCBI chr 4:178,185,418...178,218,484
|
|
G |
L1cam |
L1 cell adhesion molecule |
disease_progression |
ISO |
|
RGD |
PMID:22307136 |
RGD:11570503 |
NCBI chr X:151,597,270...151,623,776
Ensembl chr X:151,597,277...151,623,857
|
|
G |
Lamb3 |
laminin subunit beta 3 |
|
ISO |
mRNA:increased expression:lung: |
RGD |
PMID:10964684 |
RGD:13793368 |
NCBI chr13:104,833,810...104,875,405
Ensembl chr13:104,833,873...104,875,405
|
|
G |
Lamc2 |
laminin subunit gamma 2 |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:lung: |
CTD RGD |
PMID:30381462 PMID:26180921 PMID:10964684 |
RGD:13793367, RGD:13793368 |
NCBI chr13:65,284,664...65,344,164
Ensembl chr13:65,284,664...65,344,200
|
|
G |
Lep |
leptin |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:19033693 |
RGD:5128815 |
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lgals1 |
galectin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17094902 |
|
NCBI chr 7:110,485,239...110,488,345
Ensembl chr 7:110,481,392...110,488,345
|
|
G |
Lrp1b |
LDL receptor related protein 1B |
ameliorates |
ISO |
DNA:mutations:multiple: (human) |
RGD |
PMID:31164891 |
RGD:150429775 |
NCBI chr 3:24,594,302...26,715,037
Ensembl chr 3:24,594,991...26,715,505
|
|
G |
Lrrc56 |
leucine rich repeat containing 56 |
|
ISO |
ClinVar Annotator: match by term: Non-small cell lung carcinoma |
ClinVar |
PMID:2674130 PMID:3004741 PMID:3283542 PMID:3304147 PMID:6287572 PMID:6287573 PMID:6288698 PMID:10716188 PMID:21779495 PMID:24033266 PMID:25741868 PMID:28492532 PMID:29493581 More...
|
|
NCBI chr 1:196,299,843...196,315,170
Ensembl chr 1:196,299,846...196,315,172
|
|
G |
Lrrc59 |
leucine rich repeat containing 59 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30705370 |
|
NCBI chr10:79,572,295...79,586,953
Ensembl chr10:79,572,317...79,602,533
|
|
G |
Lta |
lymphotoxin alpha |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:9669810 |
RGD:4143264 |
NCBI chr20:3,618,853...3,621,324
Ensembl chr20:3,618,853...3,620,859
|
|
G |
Ltf |
lactotransferrin |
|
ISO |
|
RGD |
PMID:21532506 |
RGD:7243860 |
NCBI chr 8:110,999,948...111,022,795
Ensembl chr 8:110,999,948...111,022,795
|
|
G |
Macir |
macrophage immunometabolism regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30705370 |
|
NCBI chr 9:98,420,760...98,440,818
Ensembl chr 9:98,420,376...98,441,733
|
|
G |
Manf |
mesencephalic astrocyte-derived neurotrophic factor |
susceptibility |
ISO |
|
RGD |
PMID:8971156 |
RGD:1599219 |
NCBI chr 8:107,500,856...107,551,595
Ensembl chr 8:107,548,352...107,551,438
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
ameliorates |
ISO |
ClinVar Annotator: match by term: Non-small cell lung carcinoma ClinVar Annotator: match by term: Non-small cell lung cancer | ClinVar Annotator: match by term: Non-small cell lung carcinoma |
ClinVar RGD |
PMID:7651428 PMID:17704260 PMID:18060073 PMID:18632602 PMID:19344873 PMID:19411838 PMID:19915144 PMID:20301365 PMID:22327936 PMID:23444215 PMID:23569304 PMID:24033266 PMID:25049390 PMID:25157968 PMID:25741868 PMID:28492532 PMID:29402968 PMID:29643386 PMID:30763456 PMID:31487502 PMID:20951313 PMID:21514245 PMID:21277552 More...
|
RGD:5133242, RGD:150530476, RGD:5133243 |
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
ameliorates |
ISO |
|
RGD |
PMID:21514245 |
RGD:150530476 |
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
|
|
G |
Map2k4 |
mitogen activated protein kinase kinase 4 |
ameliorates |
ISO |
associated with Postoperative Complications;DNA:SNP:intron: (rs12452497)(human) |
RGD |
PMID:26165383 |
RGD:11521299 |
NCBI chr10:50,343,227...50,447,956
Ensembl chr10:50,344,915...50,447,993
|
|
G |
Map2k7 |
mitogen activated protein kinase kinase 7 |
susceptibility exacerbates |
ISO |
DNA:SNP:3' utr: (rs3679) (human) |
RGD |
PMID:27861856 PMID:21317887 |
RGD:155230827, RGD:155249848 |
NCBI chr12:2,591,312...2,600,534
Ensembl chr12:2,591,219...2,604,222
|
|
G |
Map3k1 |
mitogen-activated protein kinase kinase kinase 1 |
severity |
ISO |
DNA:SNPs:5'-UTR, intron 1: (rs17661089, rs16886403, rs726501) (human) |
RGD |
PMID:21636554 |
RGD:150573805 |
NCBI chr 2:43,348,572...43,414,706
Ensembl chr 2:43,350,098...43,414,463
|
|
G |
Map3k8 |
mitogen-activated protein kinase kinase kinase 8 |
disease_progression |
ISO |
|
RGD |
PMID:28393206 PMID:23533274 |
RGD:151356965, RGD:151356978 |
NCBI chr17:53,382,908...53,403,216
Ensembl chr17:53,383,131...53,403,216
|
|
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
disease_progression ameliorates severity |
ISO |
protein:increased expression:lung, cytoplasm (human) human cells in mouse model protein:increased expression:lung (human) DNA:mutations:multiple |
RGD |
PMID:24469836 PMID:31662324 PMID:32945371 PMID:29567880 PMID:32276600 PMID:27264345 More...
|
RGD:151356906 RGD:151356915 RGD:151356931, RGD:151356750, RGD:151357000, RGD:151356758 |
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19941079 PMID:21268124 |
|
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Meox1 |
mesenchyme homeobox 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:34837450 |
|
NCBI chr10:86,818,450...86,837,563
Ensembl chr10:86,818,478...86,837,660
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21623265 PMID:21815704 PMID:22787409 PMID:24688052 PMID:20519133 PMID:24092988 PMID:21277552 PMID:20951313 More...
|
RGD:5133241, RGD:13434906, RGD:5133243, RGD:5133242 |
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
|
|
G |
Mier3 |
MIER family member 3 |
|
ISO |
mRNA:decreased expression:lung |
RGD |
PMID:35117188 |
RGD:407571696 |
NCBI chr 2:43,287,546...43,316,422
Ensembl chr 2:43,287,916...43,316,136
|
|
G |
Mif |
macrophage migration inhibitory factor |
|
ISO |
|
RGD |
PMID:12576459 |
RGD:4891022 |
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504 Ensembl chr 4:12,790,902...12,799,504
|
|
G |
Mir107 |
microRNA 107 |
|
ISO |
mRNA:decreased expression:lung (human) |
RGD |
PMID:30280776 |
RGD:126925764 |
NCBI chr 1:232,337,767...232,337,853
Ensembl chr 1:232,337,767...232,337,853
|
|
G |
Mir126a |
microRNA 126a |
|
ISO |
CTD Direc | |